0001439288FALSE2022Q1--12-31http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent00014392882022-01-012022-03-3100014392882022-04-22xbrli:shares00014392882022-03-31iso4217:USD00014392882021-12-31iso4217:USDxbrli:shares00014392882021-01-012021-03-3100014392882020-12-3100014392882021-03-310001439288zws:ElkayManufacturingCompanyMember2022-02-12xbrli:pure0001439288zws:ElkayManufacturingCompanyMember2022-02-122022-02-120001439288zws:McWaneAssetsAcquisitionMember2021-11-172021-11-170001439288zws:AdvanceTechnologySolutionsLLCMember2021-04-162021-04-160001439288zws:AdvanceTechnologySolutionsLLCMember2021-04-160001439288us-gaap:EmployeeSeveranceMember2022-01-012022-03-310001439288us-gaap:EmployeeSeveranceMember2021-01-012021-03-310001439288us-gaap:ContractTerminationMember2022-01-012022-03-310001439288us-gaap:ContractTerminationMember2021-01-012021-03-310001439288us-gaap:EmployeeSeveranceMember2021-12-310001439288us-gaap:ContractTerminationMember2021-12-310001439288us-gaap:EmployeeSeveranceMember2022-03-310001439288us-gaap:ContractTerminationMember2022-03-310001439288zws:ProcessMotionControlSegmentMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-01-012022-03-310001439288us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2022-01-012022-03-310001439288us-gaap:DiscontinuedOperationsHeldforsaleMember2021-01-012021-03-310001439288zws:InstitutionalCustomerMember2022-01-012022-03-310001439288zws:InstitutionalCustomerMember2021-01-012021-03-310001439288zws:CommercialCustomerMember2022-01-012022-03-310001439288zws:CommercialCustomerMember2021-01-012021-03-310001439288us-gaap:OtherCustomerMember2022-01-012022-03-310001439288us-gaap:OtherCustomerMember2021-01-012021-03-310001439288country:US2022-01-012022-03-310001439288country:US2021-01-012021-03-310001439288country:CA2022-01-012022-03-310001439288country:CA2021-01-012021-03-310001439288zws:OtherGeographicalAreasMember2022-01-012022-03-310001439288zws:OtherGeographicalAreasMember2021-01-012021-03-3100014392882022-04-012022-03-3100014392882023-01-012022-03-310001439288us-gaap:CommonStockMember2020-12-310001439288us-gaap:AdditionalPaidInCapitalMember2020-12-310001439288us-gaap:RetainedEarningsMember2020-12-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001439288us-gaap:NoncontrollingInterestMember2020-12-310001439288us-gaap:RetainedEarningsMember2021-01-012021-03-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001439288us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001439288us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001439288us-gaap:CommonStockMember2021-03-310001439288us-gaap:AdditionalPaidInCapitalMember2021-03-310001439288us-gaap:RetainedEarningsMember2021-03-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001439288us-gaap:NoncontrollingInterestMember2021-03-310001439288us-gaap:CommonStockMember2021-12-310001439288us-gaap:AdditionalPaidInCapitalMember2021-12-310001439288us-gaap:RetainedEarningsMember2021-12-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001439288us-gaap:NoncontrollingInterestMember2021-12-310001439288us-gaap:RetainedEarningsMember2022-01-012022-03-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001439288us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001439288us-gaap:CommonStockMember2022-03-310001439288us-gaap:AdditionalPaidInCapitalMember2022-03-310001439288us-gaap:RetainedEarningsMember2022-03-310001439288us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001439288us-gaap:NoncontrollingInterestMember2022-03-310001439288zws:CentaMPHongKongCo.LimitedMemberzws:CentaMPHongKongCo.LimitedMemberzws:ProcessMotionControlSegmentMember2020-11-24utr:Rate0001439288us-gaap:CommonStockMember2015-03-310001439288us-gaap:CommonStockMember2020-01-270001439288us-gaap:CommonStockMember2022-03-310001439288us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001439288us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001439288us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310001439288us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310001439288us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001439288us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310001439288us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001439288us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001439288us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310001439288us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310001439288us-gaap:PatentsMember2022-01-012022-03-310001439288us-gaap:PatentsMember2022-03-310001439288us-gaap:CustomerRelationshipsMember2022-01-012022-03-310001439288us-gaap:CustomerRelationshipsMember2022-03-310001439288us-gaap:TradeNamesMember2022-01-012022-03-310001439288us-gaap:TradeNamesMember2022-03-310001439288us-gaap:TrademarksAndTradeNamesMember2022-03-310001439288us-gaap:PatentsMember2021-01-012021-03-310001439288us-gaap:PatentsMember2021-03-310001439288us-gaap:CustomerRelationshipsMember2021-01-012021-03-310001439288us-gaap:CustomerRelationshipsMember2021-03-310001439288us-gaap:TradeNamesMember2021-01-012021-03-310001439288us-gaap:TradeNamesMember2021-03-310001439288us-gaap:TrademarksAndTradeNamesMember2021-03-310001439288us-gaap:CustomerRelationshipsMember2021-01-012021-12-310001439288zws:CreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2022-03-310001439288zws:CreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-12-310001439288zws:FinanceLeasesAndOtherSubsidiaryDebtMember2022-03-310001439288zws:FinanceLeasesAndOtherSubsidiaryDebtMember2021-12-310001439288zws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-040001439288us-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-040001439288zws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioOneMemberzws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-040001439288us-gaap:BaseRateMemberzws:LeverageRatioScenarioOneMemberzws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioOneMemberus-gaap:LondonInterbankOfferedRateLIBORMemberzws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-042021-10-040001439288us-gaap:LondonInterbankOfferedRateLIBORMemberzws:LeverageRatioScenarioTwoMemberzws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioTwoMemberzws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2021-10-042021-10-040001439288zws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2022-03-310001439288zws:SeniorSecuredCreditFacilityMemberus-gaap:MediumTermNotesMember2022-01-012022-03-310001439288zws:LeverageRatioScenarioOneMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-040001439288us-gaap:BaseRateMemberzws:LeverageRatioScenarioOneMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioOneMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioTwoMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-040001439288zws:LeverageRatioScenarioTwoMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-042021-10-040001439288zws:LeverageRatioScenarioOneMemberus-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-10-042021-10-040001439288us-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2021-12-310001439288us-gaap:RevolvingCreditFacilityMemberzws:SeniorSecuredCreditFacilityMember2022-03-310001439288zws:OtherSubsidiaryDebtMember2022-03-310001439288zws:OtherSubsidiaryDebtMember2021-12-310001439288us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001439288us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001439288us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001439288us-gaap:FairValueMeasurementsRecurringMember2022-03-310001439288us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001439288us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001439288us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001439288us-gaap:FairValueMeasurementsRecurringMember2021-12-310001439288zws:ZurnMemberus-gaap:AsbestosIssueMember2022-03-31zws:lawsuitzws:claimant0001439288zws:ZurnMemberus-gaap:AsbestosIssueMember2022-01-012022-03-31zws:carrier0001439288us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310001439288us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001439288us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-03-310001439288us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310001439288us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001439288us-gaap:PerformanceSharesMember2022-01-012022-03-310001439288us-gaap:StockCompensationPlanMember2022-01-012022-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_________________________________________________
FORM 10-Q
|
|
|
|
|
|
|
|
|
(Mark one) |
|
|
|
|
☒ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the quarter ended March 31,
2022
|
|
|
|
|
|
|
|
|
☐
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the transition period
from to
|
|
|
|
|
|
Commission File Number: |
001-35475 |
_________________________________________________
|
|
|
ZURN WATER SOLUTIONS CORPORATION |
(Exact name of registrant as specified in its charter) |
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
20-5197013 |
(State or Other Jurisdiction of Incorporation or
Organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
511 W. Freshwater Way |
|
53204 |
Milwaukee, |
Wisconsin |
|
(Zip Code) |
(Address of Principal Executive Offices) |
|
|
Registrant’s telephone number, including area code:
(855) 480-5050
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on Which Registered |
Common Stock, $.01 par value |
ZWS |
The New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject
to such filing requirements for the past 90
days. Yes ☒ No
☐
Indicate by checkmark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such
files). Yes ☒ No
☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in
Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
☒ |
Accelerated filer |
☐ |
|
|
|
|
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
|
|
|
|
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Exchange Act Rule
12b-2). Yes ☐ No
☒
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable
date.
|
|
|
|
|
|
|
|
|
Class |
|
Outstanding at April 22, 2022
|
Zurn Water Solutions Corporation Common Stock, $0.01 par value per
share |
|
125,967,533 shares |
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
|
|
|
Item 2. |
|
|
|
|
|
Item 3. |
|
|
|
|
|
Item 4. |
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
|
|
|
Item 1A. |
|
|
|
|
|
Item 2. |
|
|
|
|
|
Item 6. |
|
|
|
|
|
|
Private Securities Litigation Reform Act Safe Harbor
Statement
Our disclosure and analysis in this report
concerning our operations, cash flows and financial position,
including, in particular, the likelihood of our success in
developing and expanding our business and the realization of sales
from our backlog, include forward-looking statements. Statements
that are predictive in nature, that depend upon or refer to future
events or conditions, or that include words such as “expects,”
“anticipates,” “intends,” “plans,” “believes,” “estimates” and
similar expressions are forward-looking statements. Although these
statements are based upon reasonable assumptions, including
projections of orders, sales, operating margins, earnings, cash
flows, research and development costs, working capital and capital
expenditures, they are subject to risks and uncertainties that are
described more fully herein and in our Annual Report on Form 10-K
for the year ended December 31, 2021, in Part I, Item 1A,
“Risk Factors” and in Part I under the heading "Cautionary Notice
Regarding Forward-Looking Statements", as well as in our other
filings with the Securities and Exchange Commission.
In addition, our previously announced transaction with Elkay
Manufacturing Company is subject to various risks, uncertainties
and factors including, among others: the inability to complete the
transaction; the inability to recognize the anticipated benefits of
the proposed transaction, including due to the failure to receive
required security holder approvals, or the failure of other closing
conditions; and costs related to the proposed transaction. See also
Part II, Item 1A, "Risk Factors" herein.
Accordingly, we can give no assurance that we will achieve the
results anticipated or implied by our forward-looking statements.
We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, except as required by
law.
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL
STATEMENTS
Zurn Water Solutions Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(in Millions, except share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
|
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
73.2 |
|
|
$ |
96.6 |
|
|
|
Receivables, net |
|
172.1 |
|
|
144.1 |
|
|
|
Inventories |
|
224.3 |
|
|
184.5 |
|
|
|
Income taxes receivable |
|
27.4 |
|
|
33.1 |
|
|
|
Other current assets |
|
23.1 |
|
|
16.5 |
|
|
|
Total current assets |
|
520.1 |
|
|
474.8 |
|
|
|
Property, plant and equipment, net |
|
63.1 |
|
|
64.4 |
|
|
|
Intangible assets, net |
|
176.9 |
|
|
179.1 |
|
|
|
Goodwill |
|
255.0 |
|
|
254.1 |
|
|
|
Insurance for asbestos claims |
|
66.0 |
|
|
66.0 |
|
|
|
Other assets |
|
37.5 |
|
|
39.3 |
|
|
|
Total assets |
|
$ |
1,118.6 |
|
|
$ |
1,077.7 |
|
|
|
Liabilities and stockholders' equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Current maturities of debt |
|
$ |
5.6 |
|
|
$ |
5.6 |
|
|
|
Trade payables |
|
113.7 |
|
|
105.1 |
|
|
|
Compensation and benefits |
|
6.6 |
|
|
22.0 |
|
|
|
Current portion of pension and postretirement benefit
obligations |
|
1.3 |
|
|
1.3 |
|
|
|
Other current liabilities |
|
87.3 |
|
|
106.4 |
|
|
|
Total current liabilities |
|
214.5 |
|
|
240.4 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
532.9 |
|
|
533.9 |
|
|
|
Pension and postretirement benefit obligations |
|
56.7 |
|
|
57.3 |
|
|
|
Deferred income taxes |
|
7.7 |
|
|
3.1 |
|
|
|
Operating lease liability |
|
7.4 |
|
|
8.9 |
|
|
|
Reserve for asbestos claims |
|
66.0 |
|
|
66.0 |
|
|
|
Other liabilities |
|
39.7 |
|
|
41.7 |
|
|
|
Total liabilities |
|
924.9 |
|
|
951.3 |
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
Common stock, $0.01 par value; 200,000,000 shares authorized;
shares issued and outstanding: 125,847,069 at March 31, 2022
and 125,720,068 at December 31, 2021
|
|
1.3 |
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
1,440.8 |
|
|
1,436.9 |
|
|
|
Retained deficit |
|
(1,175.5) |
|
|
(1,236.9) |
|
|
|
Accumulated other comprehensive loss |
|
(72.9) |
|
|
(74.9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders' equity |
|
193.7 |
|
|
126.4 |
|
|
|
Total liabilities and stockholders' equity |
|
$ |
1,118.6 |
|
|
$ |
1,077.7 |
|
|
|
See notes to the condensed consolidated financial
statements.
Zurn Water Solutions Corporation and Subsidiaries
Condensed Consolidated Statements of Operations
(in Millions, except share and per share amounts)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
Net sales |
|
$ |
239.6 |
|
|
$ |
205.2 |
|
|
|
|
|
Cost of sales |
|
137.7 |
|
116.8 |
|
|
|
|
Gross profit |
|
101.9 |
|
88.4 |
|
|
|
|
Selling, general and administrative expenses |
|
53.9 |
|
57.7 |
|
|
|
|
Restructuring and other similar charges |
|
1.1 |
|
0.6 |
|
|
|
|
Amortization of intangible assets |
|
3.0 |
|
6.1 |
|
|
|
|
Income from operations |
|
43.9 |
|
24.0 |
|
|
|
|
Non-operating expense: |
|
|
|
|
|
|
|
|
Interest expense, net |
|
(4.8) |
|
(9.6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income, net |
|
0.3 |
|
0.3 |
|
|
|
|
Income before income taxes |
|
39.4 |
|
14.7 |
|
|
|
|
Provision for income taxes |
|
(10.0) |
|
(4.7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations |
|
29.4 |
|
10.0 |
|
|
|
|
Income from discontinued operations, net of tax |
|
0.8 |
|
40.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Zurn common stockholders |
|
$ |
30.2 |
|
|
$ |
50.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per share: |
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.23 |
|
|
$ |
0.08 |
|
|
|
|
|
Discontinued operations |
|
$ |
0.01 |
|
|
$ |
0.33 |
|
|
|
|
|
Net income |
|
$ |
0.24 |
|
|
$ |
0.42 |
|
|
|
|
|
Diluted net income per share: |
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.23 |
|
|
$ |
0.08 |
|
|
|
|
|
Discontinued operations |
|
$ |
0.01 |
|
|
$ |
0.32 |
|
|
|
|
|
Net income |
|
$ |
0.24 |
|
|
$ |
0.40 |
|
|
|
|
|
Weighted-average number of shares outstanding (in
thousands): |
|
|
|
|
|
|
|
|
Basic |
|
126,281 |
|
119,808 |
|
|
|
|
Effect of dilutive equity awards |
|
2,160 |
|
3,829 |
|
|
|
|
Diluted |
|
128,441 |
|
123,637 |
|
|
|
|
See notes to the condensed consolidated financial
statements.
Zurn Water Solutions Corporation and Subsidiaries
Condensed Consolidated Statements of Comprehensive
Income
(in Millions)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
Net income |
|
$ |
30.2 |
|
|
$ |
50.0 |
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
2.0 |
|
|
(1.7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in pension and postretirement defined benefit plans, net of
tax |
|
— |
|
|
(0.1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
$ |
32.2 |
|
|
$ |
48.3 |
|
|
|
|
|
See notes to the condensed consolidated financial
statements.
Zurn Water Solutions Corporation and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in Millions)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2022 |
|
March 31, 2021 |
Operating activities |
|
|
|
|
Net income |
|
$ |
30.2 |
|
|
$ |
50.0 |
|
Adjustments to reconcile net income to cash provided by operating
activities: |
|
|
|
|
Depreciation |
|
2.3 |
|
|
14.1 |
|
Amortization of intangible assets |
|
3.0 |
|
|
9.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
4.6 |
|
|
(1.3) |
|
Other non-cash expenses |
|
0.5 |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
3.9 |
|
|
14.8 |
|
Changes in operating assets and liabilities: |
|
|
|
|
Receivables |
|
(27.7) |
|
|
(36.9) |
|
Inventories |
|
(39.6) |
|
|
(19.9) |
|
Other assets |
|
(1.1) |
|
|
3.1 |
|
Accounts payable |
|
8.4 |
|
|
50.7 |
|
Accruals and other |
|
(38.4) |
|
|
(13.4) |
|
Cash (used for) provided by operating activities |
|
(53.9) |
|
|
71.3 |
|
|
|
|
|
|
Investing activities |
|
|
|
|
Expenditures for property, plant and equipment |
|
(0.8) |
|
|
(9.2) |
|
Acquisitions, net of cash acquired |
|
— |
|
|
0.4 |
|
Proceeds from dispositions of long-lived assets |
|
1.3 |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
Proceeds associated with divestiture of discontinued
operations |
|
35.0 |
|
|
— |
|
Cash provided by (used for) investing activities |
|
35.5 |
|
|
(8.1) |
|
|
|
|
|
|
Financing activities |
|
|
|
|
Proceeds from borrowings of debt |
|
10.0 |
|
|
— |
|
Repayments of debt |
|
(11.4) |
|
|
(0.5) |
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
0.5 |
|
|
2.8 |
|
Taxes withheld and paid on employees' share-based payment
awards |
|
(0.5) |
|
|
— |
|
Repurchase of common stock |
|
— |
|
|
(0.9) |
|
Payment of common stock dividends |
|
(3.8) |
|
|
(10.8) |
|
|
|
|
|
|
Cash used for financing activities |
|
(5.2) |
|
|
(9.4) |
|
Effect of exchange rate changes on cash, cash equivalents and
restricted cash |
|
0.2 |
|
|
(2.1) |
|
(Decrease) increase in cash, cash equivalents and restricted
cash |
|
(23.4) |
|
|
51.7 |
|
Cash, cash equivalents and restricted cash at beginning of
period |
|
96.6 |
|
|
255.6 |
|
Cash, cash equivalents and restricted cash at end of
period |
|
$ |
73.2 |
|
|
$ |
307.3 |
|
See notes to the condensed consolidated financial
statements.
Zurn Water Solutions Corporation and Subsidiaries
Notes to Condensed Consolidated Financial Statements
March 31, 2022
(Unaudited)
1. Basis of Presentation and Significant Accounting
Policies
The
unaudited condensed consolidated financial statements included
herein have been prepared by Zurn Water Solutions Corporation
(“Zurn” or the “Company”) in accordance with accounting principles
generally accepted in the United States ("GAAP") pursuant to the
rules and regulations of the Securities and Exchange Commission.
Certain information and footnote disclosures normally included in
financial statements prepared in accordance with GAAP have been
condensed or omitted pursuant to such rules and regulations,
although the Company believes that the disclosures are adequate to
make the information presented not misleading.
In the opinion of management, the condensed
consolidated financial statements include all adjustments necessary
for a fair presentation of the results of operations for the
interim periods. Results for the interim periods are not
necessarily indicative of results that may be expected for the year
ending December 31, 2022. These condensed consolidated
financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto included in
the Company's Annual Report on Form 10-K for the year ended
December 31, 2021.
Spin-Off of Process & Motion Control Segment
On October 4, 2021, the Company completed a Reverse Morris Trust
tax-free spin-off transaction (the “Spin-off Transaction”) in which
(i) substantially all the assets and liabilities of the Company's
PMC business were transferred to a newly created subsidiary, Land
Newco, Inc. (“Land”), (ii) the shares of Land were distributed to
the Company's stockholders pro rata, and (iii) Land was merged with
a subsidiary of Regal Rexnord Corporation (formerly known as Regal
Beloit Corporation), in which the stock of Land was converted into
a specified number of shares of Regal Rexnord Corporation in
accordance with the exchange ratio. Following completion of the
Spin-Off Transaction, the Company's name was changed to “Zurn Water
Solutions Corporation” and the ticker symbol for its shares of
common stock trading on the New York Stock Exchange was changed to
“ZWS”.
As a result of the Spin-Off Transaction, in accordance with the
authoritative guidance, the operating results of PMC are reported
as discontinued operations in the condensed consolidated statements
of operations for all prior periods presented. The condensed
consolidated statements of cash flows has not been adjusted to
separately disclose cash flows related to the discontinued
operations. See Note 4, Discontinued Operations for additional
information.
The Company
Zurn Water Solutions Corporation is a
growth-oriented, pure-play water management business that designs,
procures, manufactures, and markets what the Company believes to be
the broadest sustainable product portfolio of specification-driven
water management solutions to improve health, human safety and the
environment. The Company's product portfolio includes professional
grade water safety and control, flow systems and hygienic and
environmental products for public and private spaces that deliver
superior value to building owners, positively impact the
environment and human hygiene and reduce product installation time.
The Company's heritage of innovation and specification has allowed
Zurn to provide highly-engineered, mission-critical solutions to
customers for decades and affords Zurn the privilege of having
long-term, valued relationships with market leaders. The Company
operates in a disciplined way and the Zurn Business System (“ZBS”),
described below, is its operating philosophy. Grounded in the
spirit of continuous improvement, ZBS creates a scalable,
process-based framework that focuses on driving superior customer
satisfaction and financial results by targeting world-class
operating performance throughout all aspects of the Company's
business.
Recent Accounting Pronouncements
In March 2020, the Financial Accounting Standards Board ("FASB")
issued Accounting Standards Update ("ASU") No. 2020-04,
Reference Rate Reform (Topic 848): Facilitation of the Effects of
Reference Rate Reform on Financial Reporting
("ASU 2020-04"). The amendments in this ASU apply only to
contracts, hedging relationships, and other transactions that
reference LIBOR or another reference rate that is expected to be
discontinued because of reference rate reform. The amendments in
this update provide optional expedients and exceptions for applying
GAAP to instruments affected by reference rate reform if certain
criteria are met. The expedients and exceptions provided by the
amendments do not apply to contract modifications made and hedging
relationships entered into or evaluated after December 31, 2022,
except for hedging relationships existing as of December 31, 2022,
that an entity has elected certain optional expedients for and that
are retained through the end of the hedging relationship. The
amendments in this ASU are effective for all entities as of March
12, 2020, through December 31, 2022. The Company did not modify any
material contracts due to reference rate reform during the
three
months ended March 31, 2022. The Company will continue to
evaluate the impact this guidance will have on its consolidated
financial statements for all future transactions affected by
reference rate reform during the time period referenced
above.
2. Acquisitions
Three Months Ended March 31, 2022
On February 12, 2022, the Company entered into a definitive
agreement to combine with Elkay Manufacturing Company (“Elkay”),
pursuant to an Agreement and Plan of Merger (the “Merger
Agreement”) by and among the Company, Elkay, Zebra Merger Sub,
Inc., a wholly-owned subsidiary of the Company (“Merger Sub”), and
Elkay Interior Systems International, Inc., as representative of
the stockholders of Elkay. The Merger Agreement provides that among
other matters, and subject to the satisfaction or waiver of the
conditions set forth in the Merger Agreement, Elkay would merge
with Merger Sub, with Elkay surviving as a wholly-owned subsidiary
of the Company (the “Merger”). Pursuant to the terms and subject to
the conditions set forth in the Merger Agreement, at the effective
time of the Merger (the “Effective Time”), the Company will
exchange, for 100% of the outstanding equity of Elkay, up to
52.5 million newly issued shares of the Company's common
stock, which on a pro forma basis, assuming closing of the Merger
on December 31, 2021 (and assuming no adjustments pursuant to the
Merger Agreement), would have represented approximately 29% of the
outstanding shares of the Company's common stock on a fully diluted
basis as of such date (the “Merger Consideration”).
The Company anticipates the Merger will close will close early in
the third quarter of 2022. The closing of the Merger is subject to
customary conditions, including, among others, the absence of laws
or orders by a governmental authority enjoining or prohibiting the
consummation of the transactions contemplated by the Merger
Agreement; the expiration or termination of the applicable waiting
period under the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (“HSR”) (which waiting period expired on March 30,
2022); the required approvals by the respective stockholders of the
Company and Elkay; a registration statement having become effective
in accordance with the provisions of the Securities Act of 1933, as
amended, and not being subject to any stop order suspending the
registration statement (registration statement became effective on
April 26, 2022); the shares of the Company's common stock to be
issued in the Merger being approved for listing on the New York
Stock Exchange as of the closing; the accuracy of the parties’
representations and warranties contained in the Merger Agreement
(subject to certain materiality qualifications); the parties’
compliance with the covenants and agreements in the Merger
Agreement in all material respects; and the absence of any material
adverse effect on the Company or Elkay.
Fiscal Year 2021
On November 17, 2021, the Company completed the acquisition of the
Wade Drains business ("Wade Drains") from McWane, Inc. for a
preliminary cash purchase price of $13.7 million, excluding
transaction costs and net of cash acquired. The preliminary
purchase price is subject to customary post-closing adjustments.
Wade Drains manufactures a wide range of specified commercial
plumbing products for customers across North America and
complements the Company's existing flow systems product
portfolio.
On April 16, 2021, the Company acquired substantially all of the
assets of Advance Technology Solutions, LLC (d/b/a ATS GREASEwatch)
("ATS GREASEwatch") for a cash purchase price of $4.5 million,
excluding transaction costs and net of cash acquired. The Company
paid $3.8 million to the sellers at closing, with the
remaining $0.7 million payable to the sellers upon settlement
of certain indemnities within two years of closing, ATS GREASEwatch
develops, manufactures and markets remote tank monitoring devices,
alarms, software and services for various applications and provides
technology to enhance and expand our current product
offerings.
The acquisitions have been accounted for as business combinations
and were recorded by allocating the purchase prices to the fair
value of assets acquired and liabilities assumed at the acquisition
dates. The excess of the purchase price over the fair value
assigned to the assets acquired and liabilities assumed was
recorded as goodwill. The preliminary purchase price allocations
associated with these acquisitions resulted in tax deductible
goodwill of $8.8 million, customer relationship intangibles
assets of $1.6 million, trade working capital of
$9.0 million and $(1.1) million of other net liabilities.
The preliminary purchase price allocations will be completed within
the one-year period following the acquisition dates.
The Company's results of operations include the acquired operations
subsequent to the acquisition dates. Pro-forma results of
operations and certain other U.S. GAAP disclosures related to these
acquisitions have not been presented because the acquisitions did
not significantly impact the Company's condensed consolidated
statements of operations or financial position.
3. Restructuring and Other Similar Charges
During the three months ended March 31, 2022, the Company
continued to execute various restructuring actions. These
initiatives were implemented to drive efficiencies and reduce
operating costs while also modifying the Company's
footprint to reflect changes in the markets it serves, the impact
of acquisitions on the Company's overall manufacturing capacity and
the refinement of its overall product portfolio. These
restructuring actions primarily resulted in workforce reductions,
lease termination costs, and other facility rationalization costs.
Management expects to continue executing initiatives and select
product-line rationalizations to optimize its operating margin and
manufacturing footprint. As such, the Company expects further
expenses related to workforce reductions, lease termination costs,
and other facility rationalization costs. Since the Company’s
evaluation of other potential restructuring actions are in process,
related restructuring expenses, if any, are not yet
estimable.
The following table summarizes the
Company's restructuring and other similar charges during the three
months ended March 31, 2022 and March 31, 2021, (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
|
|
|
|
Employee termination benefits |
|
$ |
1.1 |
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
|
Contract termination and other associated costs |
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
Total restructuring and other similar costs |
|
$ |
1.1 |
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
|
The following table summarizes the activity in the Company's
restructuring accrual for the three months ended March 31,
2022 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee termination benefits |
|
Contract termination and other associated costs |
|
Total |
|
Accrued Restructuring Costs, December 31, 2021 (1) |
|
$ |
2.4 |
|
|
$ |
— |
|
|
$ |
2.4 |
|
|
Charges |
|
1.1 |
|
|
— |
|
|
$ |
1.1 |
|
|
Cash payments |
|
(2.2) |
|
|
— |
|
|
$ |
(2.2) |
|
|
|
|
|
|
|
|
|
|
Accrued Restructuring Costs, March 31, 2022 (1) |
|
$ |
1.3 |
|
|
$ |
— |
|
|
$ |
1.3 |
|
|
____________________
(1)The
restructuring accrual is included in other current liabilities in
the condensed consolidated balance sheets.
4. Discontinued Operations
During the year ended December 31, 2021, the Company completed the
Spin-Off Transaction of PMC. The operating results of PMC are
reported as discontinued operations in the consolidated statements
of operations for all prior periods presented, as the Spin-Off
Transaction of PMC represented a strategic shift that had a major
impact on operations and financial results. The condensed
consolidated statements of cash flows for the three months ended
March 31, 2021 has not been adjusted to separately disclose
cash flows related to the discontinued operations. During the three
months ended March 31, 2022, the Company received
$35.0 million from Regal Rexnord Corporation as a result of
the final working capital and cash balances at closing exceeded the
targets stipulated within the Spin-Off Transaction
agreement.
The major components of the Income from discontinued operations,
net of tax presented in the condensed consolidated statements of
operations for the three months ended March 31, 2022 and
March 31, 2021, are as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2022 |
|
March 31, 2021 |
Net sales |
|
$ |
— |
|
|
$ |
320.9 |
|
Cost of sales |
|
— |
|
|
(201.4) |
|
Selling, general and administrative expenses |
|
— |
|
|
(61.6) |
|
|
|
|
|
|
Amortization of intangible assets |
|
— |
|
|
(3.3) |
|
Interest expense, net |
|
— |
|
|
(1.4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense, net |
|
— |
|
|
(0.7) |
|
Income from discontinued operations before income tax |
|
— |
|
|
52.5 |
|
|
|
|
|
|
Income tax benefit (provision) |
|
0.8 |
|
|
(12.5) |
|
Equity method investment income |
|
— |
|
|
0.1 |
|
Non-controlling interest income |
|
— |
|
|
0.1 |
|
Income from discontinued operations, net of tax |
|
$ |
0.8 |
|
|
$ |
40.0 |
|
The condensed consolidated statements of cash flows for the three
months ended March 31, 2022 and March 31, 2021 have not
been adjusted to separately disclose cash flows related to
discontinued operations. However, the significant investing and
financing cash flows and other significant non-cash operating items
associated with the discontinued operations were as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2022 |
|
March 31, 2021 |
Depreciation |
|
$ |
— |
|
|
$ |
11.9 |
|
Amortization of intangible assets |
|
— |
|
|
3.3 |
|
Loss on disposition of assets |
|
— |
|
|
0.2 |
|
Deferred income taxes |
|
— |
|
|
0.1 |
|
|
|
|
|
|
Other non-cash charges |
|
— |
|
|
0.3 |
|
|
|
|
|
|
Stock-based compensation |
|
— |
|
|
5.7 |
|
Expenditures for property, plant and equipment |
|
— |
|
|
(8.2) |
|
|
|
|
|
|
Proceeds from dispositions of long-lived assets |
|
— |
|
|
0.7 |
|
Proceeds associated with divestiture of discontinued
operations |
|
35.0 |
|
|
— |
|
Repayments of debt |
|
— |
|
|
(0.5) |
|
Proceeds from exercise of stock options |
|
— |
|
|
2.4 |
|
|
|
|
|
|
|
|
|
|
|
5. Revenue Recognition
A performance obligation is a promise in a
contract to transfer a distinct good or service to the customer,
and is the unit of account in Accounting Standards Codification
("ASC") 606,
Revenue from Contracts with Customers.
A contract’s transaction price is allocated to each distinct
performance obligation and revenue is recognized when obligations
under the terms of a contract with the customer are satisfied. For
the majority of the Company's product sales, revenue is recognized
at a point-in-time when control of the product is transferred to
the customer, which generally occurs when the product is shipped
from the Company's manufacturing facility to the customer. When
contracts include multiple products to be delivered to the
customer, generally each product is separately priced and is
determined to be distinct within the context of the contract. Other
than a standard assurance-type warranty that the product will
conform to agreed-upon specifications, there are generally no other
significant post-shipment obligations. The expected costs
associated with standard warranties continues to be recognized as
an expense when the products are sold.
When the contract provides the customer the right to return
eligible products or when the customer is part of a sales rebate
program, the Company reduces revenue at the point of sale using
current facts and historical experience by using an estimate for
expected product returns and rebates associated with the
transaction. The Company adjusts these estimates at the earlier of
when the most likely amount of consideration that is expected to be
received changes or when the consideration becomes fixed.
Accordingly, an increase or decrease to revenue is recognized at
that time.
Sales and other taxes collected concurrent with revenue-producing
activities are excluded from revenue. The Company has elected to
recognize the cost for freight and shipping when control of
products has transferred to the customer as a
component of cost of sales in the consolidated statements of
operations. The Company classifies shipping and handling fees
billed to customers as net sales and the corresponding costs are
classified as cost of sales in the consolidated statements of
operations.
Revenue by Category
The following tables present the Company's revenue disaggregated by
customer type and customer geography (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Customer Type |
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
Institutional |
|
$ |
87.6 |
|
|
$ |
76.4 |
|
|
|
|
|
Commercial |
|
75.5 |
|
|
64.8 |
|
|
|
|
|
All other |
|
76.5 |
|
|
64.0 |
|
|
|
|
|
Total |
|
$ |
239.6 |
|
|
$ |
205.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Geography |
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
United States |
|
$ |
219.6 |
|
|
$ |
185.7 |
|
|
|
|
|
Canada |
|
15.1 |
|
|
14.5 |
|
|
|
|
|
Rest of world |
|
4.9 |
|
|
5.0 |
|
|
|
|
|
Total |
|
$ |
239.6 |
|
|
$ |
205.2 |
|
|
|
|
|
Contract Balances
For substantially all of the Company's product sales, the customer
is billed 100% of the contract value when the product ships and
payment is generally due 30 days from shipment. Certain contracts
include longer payment periods; however, the Company has elected to
utilize the practical expedient in which the Company will only
recognize a financing component to the sale if payment is due more
than one year from the date of shipment.
Billings are recorded as accounts receivable when an unconditional
right to the contractual consideration exists. Contract assets
arise when the Company performs by transferring goods or services
to a customer before the customer pays consideration, or before the
customer’s payment is due. A contract liability exists when the
Company has received consideration or the amount is due from the
customer in advance of revenue recognition. Contract liabilities
and contract assets as of March 31, 2022 and March 31,
2021 were not material.
Backlog
The Company had backlog
of $100.8 million as of March 31, 2022,
which represents the most likely amount of consideration expected
to be received in satisfying the remaining backlog under open
contracts. The Company has elected to use the optional exemption
provided by ASC 606-10-50-14A for variable consideration, and has
not included estimated rebates in the amount of unsatisfied
performance obligations. The Company expects to recognize
approximately 99% of the backlog in the remaining nine months of
the year ending December 31, 2022, and the remaining
approximately 1% in 2023 and beyond.
Timing of Performance Obligations Satisfied at a Point in
Time
The Company determined that the customer is able to control the
product when it is delivered to them; thus, depending on the
shipping terms, control will transfer at different points between
the Company's manufacturing facility or warehouse and the
customer’s location. The Company considers control to have
transferred upon shipment or delivery because the Company has a
present right to payment at that time, the customer has legal title
to the asset, the Company has transferred physical possession of
the asset and the customer has significant risks and rewards of
ownership of the asset.
Variable Consideration
The Company provides volume-based rebates and the right to return
product to certain customers, which are accrued for based on
current facts and historical experience. Rebates are paid either on
an annual or quarterly basis. There are no other significant
variable consideration elements included in the Company's contracts
with customers.
Contract Costs
The Company has elected to expense contract costs as incurred if
the amortization period is expected to be one year or less. If the
amortization period of these costs is expected to be greater than
one year, the costs would be subject to
capitalization. As of March 31, 2022 and March 31, 2021,
the contract assets capitalized, as well as amortization recognized
in the three months ended March 31, 2022 and March 31,
2021, are not significant and no impairment losses were
recognized.
Allowance for Doubtful Accounts
The Company assesses the collectability of customer receivables
based on the credit worthiness of a customer as determined by
credit checks and analysis, as well as the customer’s payment
history. In determining the allowance for doubtful accounts, the
Company also considers various factors including the aging of
customer accounts and historical write-offs. In addition, the
Company monitors other risk factors, including forward-looking
information when establishing adequate allowances for doubtful
accounts, which reflects the current estimate of credit losses
expected to be incurred over the life of the
receivables.
6. Income Taxes
The provision for income taxes for all periods presented is based
on an estimated effective income tax rate for the respective fiscal
years. The estimated annual effective income tax rate is determined
excluding the effect of significant discrete items or items that
are reported net of their related tax effects. The tax effect of
significant discrete items is reflected in the period in which they
occur. The Company's income tax expense is impacted by a number of
factors, including the amount of taxable earnings derived in
foreign jurisdictions with tax rates that are generally higher than
the U.S. federal statutory rate, state tax rates in the
jurisdictions where the Company does business and the Company's
ability to utilize various tax credits, capital loss and net
operating loss (“NOL”) carryforwards.
The Company regularly reviews its deferred tax assets for
recoverability and valuation allowances are established based on
historical losses, projected future taxable income and the expected
timing of the reversals of existing temporary differences, as
deemed appropriate. In addition, all other available positive and
negative evidence is taken into consideration for purposes of
determining the proper balances of such valuation allowances. As a
result of this review, the Company continues to maintain a full
valuation allowance against U.S. federal and state capital loss
carryforwards and a partial valuation allowance against certain
foreign NOL carryforwards and other related foreign deferred tax
assets, as well as certain U.S. state NOL carryforwards. Future
changes to the balances of these valuation allowances, as a result
of this continued review and analysis by the Company, could result
in a material impact to the financial statements for such period of
change.
The income tax provision was $10.0 million for the three
months ended March 31, 2022, compared to $4.7 million for
the three months ended March 31, 2021. The effective income
tax rate for the three months ended March 31, 2022, was 25.4%
versus 32.0% for the three months ended March 31, 2021. The
effective income tax rate for the three months ended March 31,
2022 was above the U.S. federal statutory rate of 21% primarily due
to the accrual of foreign income taxes, which are generally above
the U.S. federal statutory rate, the accrual of additional income
taxes associated with compensation deduction limitations under
Section 162(m) of the Internal Revenue Code and the accrual of
various state income taxes, partially offset by the recognition of
certain previously unrecognized tax benefits due to the lapse of
the applicable statutes of limitations and income tax benefits
associated with share-based payments. The effective income tax rate
for the three months ended March 31, 2021 was above the U.S.
federal statutory rate of 21% primarily due to the accrual of
foreign income taxes, which are generally above the U.S. federal
statutory rate, the accrual of additional income taxes associated
with compensation deduction limitations under Section 162(m) of the
Internal Revenue Code, and the accrual of various state income
taxes, partially offset by the recognition of income tax benefits
associated with foreign-derived intangible income
(“FDII”).
The Company’s total liability for net unrecognized tax benefits as
of March 31, 2022 and December 31, 2021 was
$4.9 million and $5.9 million, respectively. The Company
recognizes accrued interest and penalties related to unrecognized
income tax benefits in income tax expense. As of March 31,
2022 and December 31, 2021, the total amount of gross,
unrecognized income tax benefits included accrued interest and
penalties of $0.3 million and $0.5 million, respectively.
The Company recognized $(0.1) million and $0.0 million of
net interest and penalties as income tax expense (benefit) during
the three months ended March 31, 2022 and March 31, 2021,
respectively.
The Company conducts business in multiple locations within and
outside the U.S. Consequently, the Company is subject to periodic
income tax examinations by domestic and foreign income tax
authorities. Currently, the Company is undergoing routine, periodic
income tax examinations in foreign jurisdictions. During the nine
month Transition Period ended December 31, 2020, the Internal
Revenue Service (the “IRS”) completed an income tax examination of
the Company’s U.S. consolidated federal income tax returns for the
tax years ended March 31, 2016 and 2017. The Company paid
approximately $1.5 million upon the conclusion of such
examination, all of which was previously accrued in the Company’s
financial statements. In accordance with the terms of the VAG sale
agreement, the Company is required to indemnify the purchaser for
any future income tax liabilities associated with all open tax
years ending prior to, and including, the short period ended on the
date of the Company's sale of VAG. VAG was notified by the German
tax authorities of its intention to conduct an income tax
examination of the VAG German entities’ corporate income and trade
tax returns for the tax years ended March 31, 2014 through 2019.
Similarly, in accordance with the Spin-Off Transaction, the Company
is required to indemnify Regal Rexnord
Corporation for any future income tax liabilities associated with
PMC entities relating to all open tax years ending prior to, and
including, the short period ended on the date of the Spin-Off.
During the fiscal year ended March 31, 2020, the Italian tax
authorities began conducting an income tax examination of the
income tax return of one of PMC’s Italian subsidiaries for the tax
year ended March 31, 2018. In addition, certain of the PMC German
subsidiaries are currently undergoing a corporate income and trade
tax examination by the German tax authorities for the tax years or
periods ended March 31, 2015 through March 31, 2018. It appears
reasonably possible that the amounts of unrecognized income tax
benefits and indemnification liabilities could change in the next
twelve months upon conclusion of the current ongoing examinations;
however, any potential payments of income tax, interest and
penalties are not expected to be significant to the Company's
consolidated financial statements. With certain exceptions, the
Company is no longer subject to U.S. federal income tax
examinations for tax years ending prior to March 31, 2019, state
and local income tax examinations for years ending prior to March
31, 2018 or significant foreign income tax examinations for years
ending prior to March 31, 2017.
7. Earnings per Share
Basic net income per share from continuing
and discontinued operations attributable to Zurn common
stockholders is computed by dividing net income from continuing
operations and income from discontinued operations attributable to
Zurn common stockholders, respectively, by the corresponding
weighted average number of common shares outstanding for the
period. Diluted net income per share from continuing and
discontinued operations attributable to Zurn common stockholders is
computed based on the weighted average number of common shares
outstanding, increased by the number of incremental shares that
would have been outstanding if the potential dilutive shares were
issued through the exercise of outstanding stock options to
purchase common shares, except when the effect would be
anti-dilutive.
The computation for diluted net income per share for the three
months ended March 31, 2022 and March 31, 2021, excludes
0.2 million and 0.2 million common shares due to their
anti-dilutive effects, respectively.
8. Stockholders' Equity
Stockholders' equity consists of the following (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock (1) |
|
|
|
Additional paid-in capital |
|
Retained earnings |
|
Accumulated other comprehensive loss |
|
|
|
Non-controlling interest (2) |
|
Total stockholders’ equity |
Balance at December 31, 2020 |
$ |
1.2 |
|
|
|
|
$ |
1,392.9 |
|
|
$ |
116.0 |
|
|
$ |
(73.8) |
|
|
|
|
$ |
3.0 |
|
|
$ |
1,439.3 |
|
Total comprehensive income (loss) |
— |
|
|
|
|
— |
|
|
50.0 |
|
|
(1.8) |
|
|
|
|
0.1 |
|
|
48.3 |
|
Stock-based compensation expense |
— |
|
|
|
|
14.2 |
|
|
— |
|
|
— |
|
|
|
|
— |
|
|
14.2 |
|
Proceeds from exercise of stock options |
— |
|
|
|
|
2.8 |
|
|
— |
|
|
— |
|
|
|
|
— |
|
|
2.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of common stock |
— |
|
|
|
|
— |
|
|
(0.9) |
|
|
— |
|
|
|
|
— |
|
|
(0.9) |
|
Common stock dividends ($0.09 per share)
|
— |
|
|
|
|
— |
|
|
(10.8) |
|
|
— |
|
|
|
|
— |
|
|
(10.8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2021 |
$ |
1.2 |
|
|
|
|
$ |
1,409.9 |
|
|
$ |
154.3 |
|
|
$ |
(75.6) |
|
|
|
|
$ |
3.1 |
|
|
$ |
1,492.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock (1) |
|
|
|
Additional
paid-in
capital |
|
Retained
deficit |
|
Accumulated
other
comprehensive
loss |
|
|
|
Non-controlling interest |
|
Total
stockholders’
equity |
Balance at December 31, 2021 |
$ |
1.3 |
|
|
|
|
$ |
1,436.9 |
|
|
$ |
(1,236.9) |
|
|
$ |
(74.9) |
|
|
|
|
$ |
— |
|
|
$ |
126.4 |
|
Total comprehensive income |
— |
|
|
|
|
— |
|
|
30.2 |
|
|
2.0 |
|
|
|
|
— |
|
|
32.2 |
|
Stock-based compensation expense |
— |
|
|
|
|
3.9 |
|
|
— |
|
|
— |
|
|
|
|
— |
|
|
3.9 |
|
Proceeds from exercise of stock options |
— |
|
|
|
|
0.5 |
|
|
— |
|
|
— |
|
|
|
|
— |
|
|
0.5 |
|
Taxes withheld and paid on employees' share-based payment
awards |
— |
|
|
|
|
(0.5) |
|
|
— |
|
|
— |
|
|
|
|
— |
|
|
(0.5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds associated with divestiture of discontinued
operations |
— |
|
|
|
|
— |
|
|
35.0 |
|
|
— |
|
|
|
|
— |
|
|
35.0 |
|
Common stock dividends ($0.03 per share)
|
— |
|
|
|
|
— |
|
|
(3.8) |
|
|
— |
|
|
|
|
— |
|
|
(3.8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2022 |
$ |
1.3 |
|
|
|
|
$ |
1,440.8 |
|
|
$ |
(1,175.5) |
|
|
$ |
(72.9) |
|
|
|
|
$ |
— |
|
|
$ |
193.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
____________________
(1)During
the three months ended March 31, 2022 and March 31, 2021,
the Company issued 127,001 and 189,629 shares of common stock upon
the exercise of stock options, vesting of restricted stock units,
and for other common stock awards, respectively.
(2)Non-controlling
interest through the Spin-Off Transaction represents a 5%
non-controlling interest in a PMC joint venture relationship. The
Company has no remaining non-controlling interest subsequent to the
Spin-Off Transaction.
Prior year amounts disclosed within this note include amounts
attributable to the Company's discontinued operations, unless
otherwise noted. Refer to Note 4 Discontinued Operations for
further detail.
Share Repurchase Program
During fiscal 2015, the Company's Board of
Directors approved a common stock repurchase program (the
"Repurchase Program") authorizing the repurchase of up to $200.0
million of the Company's common stock from time to time on the open
market or in privately negotiated transactions. On January 27,
2020, the Company's Board of Directors approved increasing the
remaining share repurchase authority under the Repurchase Program
to $300.0 million. The Repurchase Program does not require the
Company to acquire any particular amount of common stock and does
not specify the timing of purchases or the prices to be paid;
however, the program will continue until the maximum amount of
dollars authorized have been expended or until it is modified or
terminated by the Board. The Company did not repurchase any shares
during the three months ended March 31, 2022. During the three
months ended March 31, 2021, the Company repurchased 22,300
shares of common stock at a total cost of $0.9 million at a
weighted average price of $39.27 per share. The repurchased shares
were canceled by the Company upon receipt. A total of approximately
$162.8 million of the existing authority remained under the
Repurchase Program at
March 31, 2022.
9. Accumulated Other Comprehensive Loss
The
changes in accumulated other comprehensive loss, net of tax, for
the three months ended March 31, 2022, are as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Translation and Other |
|
Pension and Postretirement Plans |
|
Total |
Balance at December 31, 2021 |
|
|
|
$ |
(70.9) |
|
|
$ |
(4.0) |
|
|
$ |
(74.9) |
|
Other comprehensive loss before reclassifications |
|
|
|
2.0 |
|
|
— |
|
|
2.0 |
|
Amounts reclassified from accumulated other comprehensive
loss |
|
|
|
— |
|
|
— |
|
|
— |
|
Net current period other comprehensive income |
|
|
|
2.0 |
|
|
— |
|
|
2.0 |
|
Balance at March 31, 2022 |
|
|
|
$ |
(68.9) |
|
|
$ |
(4.0) |
|
|
$ |
(72.9) |
|
The following table summarizes the amounts reclassified from
accumulated other comprehensive loss to net income during the three
months ended March 31, 2022 and March 31, 2021 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
|
Income Statement Line |
Pension and other postretirement plans |
|
|
|
|
|
|
|
|
|
|
Amortization of prior service credit |
|
$ |
— |
|
|
$ |
(0.1) |
|
|
|
|
|
|
Other income, net |
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
— |
|
|
— |
|
|
|
|
|
|
|
Total net of tax |
|
$ |
— |
|
|
$ |
(0.1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10. Inventories
The major classes of inventories are summarized as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
Finished goods |
|
$ |
200.8 |
|
|
$ |
169.1 |
|
Work in progress |
|
4.4 |
|
|
5.1 |
|
|
|
|
|
|
Raw materials |
|
20.6 |
|
|
14.6 |
|
Inventories at First-in, First-Out ("FIFO") cost |
|
225.8 |
|
|
188.8 |
|
Adjustment to state inventories at Last-in, First-Out ("LIFO")
cost |
|
(1.5) |
|
|
(4.3) |
|
|
|
$ |
224.3 |
|
|
$ |
184.5 |
|
11. Goodwill and Intangible Assets
The changes in the net carrying value of
goodwill for the three months ended March 31, 2022, are
presented below (in millions):
|
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2021 |
|
$ |
254.1 |
|
Currency translation adjustments |
|
0.9 |
|
|
|
|
|
|
|
Net carrying amount as of March 31, 2022 |
|
$ |
255.0 |
|
The gross carrying amount and accumulated
amortization for each major class of identifiable intangible assets
as of March 31, 2022 and December 31, 2021 are as follows
(in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
|
Weighted Average Useful Life |
|
Gross Carrying Amount |
|
Accumulated Amortization |
|
Net Carrying Amount |
Intangible assets subject to amortization: |
|
|
|
|
|
|
|
|
Patents |
|
9 years |
|
$ |
25.1 |
|
|
$ |
(22.4) |
|
|
$ |
2.7 |
|
Customer relationships (including distribution network) |
|
15 years |
|
351.7 |
|
|
(271.8) |
|
|
79.9 |
|
Tradenames |
|
12 years |
|
11.5 |
|
|
(4.3) |
|
|
7.2 |
|
Intangible assets not subject to amortization - trademarks and
tradenames |
|
|
|
87.1 |
|
|
— |
|
|
87.1 |
|
Total intangible assets, net |
|
15 years |
|
$ |
475.4 |
|
|
$ |
(298.5) |
|
|
$ |
176.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
Weighted Average Useful Life |
|
Gross Carrying Amount |
|
Accumulated Amortization |
|
Net Carrying Amount |
Intangible assets subject to amortization: |
|
|
|
|
|
|
|
|
Patents |
|
9 years |
|
$ |
24.9 |
|
|
$ |
(22.4) |
|
|
$ |
2.5 |
|
Customer relationships (including distribution network) |
|
15 years |
|
351.1 |
|
|
(269.1) |
|
|
82.0 |
|
Tradenames |
|
13 years |
|
11.5 |
|
|
(4.0) |
|
|
7.5 |
|
Intangible assets not subject to amortization - trademarks and
tradenames |
|
|
|
87.1 |
|
|
— |
|
|
87.1 |
|
Total intangible assets, net |
|
15 years |
|
$ |
474.6 |
|
|
$ |
(295.5) |
|
|
$ |
179.1 |
|
Intangible asset amortization expense
totaled $3.0 million and $6.1 million for the three months
ended March 31, 2022 and March 31, 2021, respectively.
Customer relationships acquired during the year ended
December 31, 2021 were assigned a weighted-average useful life
of 10 years. There were no intangible assets acquired during the
three months ended March 31, 2022.
The Company expects to recognize
amortization expense on the intangible assets subject to
amortization of $7.9 million in the year ending December 31,
2022 (inclusive of the $3.0 million of amortization expense
recognized in the three months ended March 31, 2022), $6.5
million in 2023, $6.5 million in 2024, $6.5 million in 2025, $6.3
million in 2026 and $6.3 million in 2027.
12. Other Current Liabilities
Other current liabilities are summarized as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
Commissions |
|
$ |
8.5 |
|
|
$ |
8.1 |
|
|
|
|
|
|
Current portion of operating lease
liability |
|
6.2 |
|
|
6.1 |
|
Income taxes payable |
|
1.9 |
|
|
2.1 |
|
|
|
|
|
|
Legal and environmental |
|
3.0 |
|
|
3.0 |
|
Product warranty (1) |
|
1.3 |
|
|
1.3 |
|
Restructuring and other similar charges (2) |
|
1.3 |
|
|
2.4 |
|
Risk management (3) |
|
11.0 |
|
|
11.3 |
|
Sales rebates |
|
23.5 |
|
|
38.6 |
|
Taxes payable on behalf of PMC |
|
21.9 |
|
|
21.9 |
|
Taxes, other than income taxes |
|
1.6 |
|
|
1.8 |
|
Other |
|
7.1 |
|
|
9.8 |
|
|
|
$ |
87.3 |
|
|
$ |
106.4 |
|
____________________
(1)See
more information related to the product warranty obligations within
Note 15, Commitments and Contingencies.
(2)See
more information related to the restructuring obligations within
Note 3, Restructuring and Other Similar Charges.
(3) Includes projected liabilities related
to losses arising from automobile, general and product liability
claims.
13. Long-Term Debt
Long-term debt is summarized as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
Term loan (1) |
|
$ |
538.2 |
|
|
$ |
539.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance leases and other subsidiary debt (2) |
|
0.3 |
|
|
0.3 |
|
Total |
|
538.5 |
|
|
539.5 |
|
Less current maturities |
|
5.6 |
|
|
5.6 |
|
Long-term debt |
|
$ |
532.9 |
|
|
533.9 |
|
____________________
(1)Includes
unamortized debt issuance costs of $10.4 million and
$10.8 million
at March 31, 2022 and December 31, 2021,
respectively.
(2)Refer
to Note 14, Leases, to the audited consolidated financial
statements included in the Company's Annual Report on Form 10-K for
the year ended December 31, 2021 for further information
regarding leases.
Senior Secured Credit Facility
On October 4, 2021, ZBS Global, Inc.
(“Holdings”), Zurn Holdings, Inc., Zurn LLC (together, the
“Borrowers”), the lenders from time to time party thereto, and
Credit Suisse AG, Cayman Islands Branch, as administrative agent
for the lenders (in such capacity, the “Administrative Agent”)
entered into a Fourth Amended and Restated First Lien Credit
Agreement (the “Credit Agreement”). The Credit Agreement is funded
by a syndicate of banks and other financial institutions and
provides for (i) a $550.0 million term loan facility (the
“Term Loan”) and (ii) a $200.0 million revolving credit
facility (the “Revolving Credit Facility”).
The obligations under the Credit Agreement and related documents
are secured by liens on substantially all of the assets of
Holdings, the Borrowers, and certain subsidiaries of the Borrowers
pursuant to a Third Amended and Restated Guarantee and Collateral
Agreement, dated as of October 4, 2021, among Holdings, the
Borrowers, the subsidiaries of the Borrowers party thereto, and the
Administrative Agent, and certain other collateral
documents.
The Credit Agreement contains representations, warranties,
covenants and events of default, including, without limitation, a
financial covenant under which the Borrowers are, if certain
conditions are met, obligated to maintain on a consolidated basis,
as of the end of each fiscal quarter, a certain maximum Net First
Lien Leverage Ratio (as defined in the Credit Agreement). As of
March 31, 2022, the Borrowers were in compliance with all
applicable covenants under the Credit Agreement.
Term Debt
The Term Loan has a maturity date of October 4, 2028. Commencing on
March 31, 2022, the Borrowers are required to make quarterly
payments of principal in an amount equal to $1.4 million on
each quarter until the maturity date.
The Term Loan bears interest at the Borrowers’ option, by reference
to a base rate or a rate based on LIBOR, in either case, plus an
applicable margin determined quarterly based on the Borrowers’ Net
First Lien Leverage Ratio as of the last day of each fiscal
quarter. If the Net First Lien Leverage Ratio is greater than 1.80
to 1.00, the applicable margin shall equal 1.25% in the case of
base rate borrowings and 2.25% in the case of LIBOR borrowings. In
the event the Borrowers’ Net First Lien Leverage Ratio is less than
or equal to 1.80 to 1.0, the applicable margin on both base rate
and LIBOR borrowings would decrease by 0.25%. The Borrowers’ Net
First Lien Leverage Ratio was 2.36 to 1.0 as of March 31,
2022. Certain prepayments of the Term Loan occurring on or prior to
April 4, 2022 are subject to a 1.00% prepayment
penalty.
At March 31, 2022 and for the three months ended, the
borrowings under the Term Loan had weighted-average effective
interest rates of 2.75% and 2.75%, respectively.
Revolving Credit Facility
The Credit Agreement includes a $200.0 million revolving
credit facility that has a maturity date of October 2, 2026.
Borrowings under the Revolving Credit Facility bear interest at the
Borrowers’ option, by reference to a base rate or a rate based on
LIBOR, in either case, plus an applicable margin determined
quarterly based on the Borrowers’ Net First Lien Leverage Ratio as
of the last day of each fiscal quarter. If the Net First Lien
Leverage Ratio is greater than 2.00 to 1.00, the applicable margin
shall equal 1.00% in the case of base rate borrowings and 2.00% in
the case of LIBOR borrowings. In the event the Borrowers' Net First
Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the
applicable margin on both base rate and LIBOR borrowings would
decrease by 0.25%. The Borrowers’ Net First Lien Leverage Ratio was
2.36 to 1.0 as of March 31, 2022. The Borrowers are also
required to pay a quarterly commitment fee on the average daily
unused portion of the
Revolving Credit Facility for each fiscal quarter and fees in
connection with the issuance of letters of credit. If the Net First
Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment
fee shall equal 0.50%, and if the Company's Net First Lien Leverage
Ratio is less than or equal to 2.00 to 1.00, the commitment fee
shall equal 0.375%.
At March 31, 2022 and December 31, 2021, there were no
amounts borrowed under the Revolving Credit Facility. As of
March 31, 2022 and December 31, 2021, $6.1 million
and $6.1 million of the Revolving Credit Facility were
considered utilized in connection with outstanding letters of
credit, respectively.
Finance leases and other subsidiary debt
At March 31, 2022 and December 31, 2021, various wholly
owned subsidiaries had additional debt of $0.3 million and
$0.3 million, respectively, comprised primarily of finance
lease obligations. See Note 14, Leases in the audited consolidated
financial statements of the Company's Annual Report on Form 10-K
for the year ended December 31, 2021 for further information
regarding leases.
14. Fair Value Measurements
ASC 820 defines fair value as the exchange
price that would be received for an asset or paid to transfer a
liability (an exit price) in the principal or most advantageous
market for the asset or liability in an orderly transaction between
market participants. ASC 820 also specifies a fair value hierarchy
based upon the observability of inputs used in valuation
techniques. Observable inputs (highest level) reflect market data
obtained from independent sources, while unobservable inputs
(lowest level) reflect internally developed assumptions about the
assumptions a market participant would use.
In accordance with ASC 820, fair value measurements are classified
under the following hierarchy:
•Level
1 - Quoted prices for identical instruments in active
markets.
•Level
2 - Quoted prices for similar instruments; quoted prices for
identical or similar instruments in markets that are not active;
and model-derived valuations in which all significant inputs or
significant value-drivers are observable.
•Level
3 - Model-derived valuations in which one or more inputs or
value-drivers are both significant to the fair value measurement
and unobservable.
If applicable, the Company uses quoted
market prices in active markets to determine fair value, and
therefore classifies such measurements within Level 1. In some
cases where market prices are not available, the Company makes use
of observable market based inputs to calculate fair value, in which
case the measurements are classified within Level 2. If quoted or
observable market prices are not available, fair value is based
upon internally developed models that use, where possible, current
market-based parameters. These measurements are classified within
Level 3 if they use significant unobservable inputs.
Fair Value of Financial Instruments
The Company has a nonqualified deferred
compensation plan where assets are invested in mutual funds and
corporate-owned life insurance contracts held in a rabbi trust,
which is restricted for payments to participants of the plan. The
Company has elected to use the fair value option for the mutual
funds, which are measured using quoted prices of identical
instruments in active markets categorized as Level 1.
Corporate-owned life insurance contracts are recorded at cash
surrender value, which is provided by a third party and reflects
the net asset value of the underlying publicly traded mutual funds
categorized as Level 2. The deferred compensation plan assets are
classified within other assets on the condensed consolidated
balance sheets. Deferred compensation plan liabilities are measured
at fair value based on quoted prices of identical instruments to
the investment vehicles selected by the participants categorized as
Level 1. Deferred compensation plan liabilities are classified
within other liabilities on the condensed consolidated balance
sheets.
The following table provides a summary of
the Company's assets and liabilities that were recognized at fair
value on a recurring basis as of March 31, 2022 and
December 31, 2021 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value as of March 31, 2022 |
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Deferred compensation plan assets |
|
$ |
1.8 |
|
|
$ |
13.2 |
|
|
$ |
— |
|
|
$ |
15.0 |
|
Deferred compensation plan liabilities |
|
15.9 |
|
|
— |
|
|
— |
|
|
15.9 |
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value as of December 31, 2021 |
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Deferred compensation plan assets |
|
$ |
0.9 |
|
|
$ |
14.4 |
|
|
$ |
— |
|
|
$ |
15.3 |
|
Deferred compensation plan liabilities |
|
16.3 |
|
|
— |
|
|
— |
|
|
16.3 |
|
There were no transfers of assets between levels at March 31,
2022 and December 31, 2021, respectively.
Fair Value of Non-Derivative Financial Instruments
The carrying amounts of cash, receivables,
payables and accrued liabilities approximated fair value at
March 31, 2022 and December 31, 2021, due to the
short-term nature of those instruments. The fair value of long-term
debt as of March 31, 2022 and December 31, 2021, was
approximately $545.5 million and $552.4 million,
respectively. The fair value is based on quoted market prices for
the same instruments.
Long-lived Assets and Intangible Assets
Long-lived assets (which include property,
plant and equipment and real estate) may be measured at fair value
if such assets are held-for-sale or when there is a determination
that the asset is impaired. Intangible assets (which include
patents, tradenames, customer relationships, and non-compete
agreements) also may be measured at fair value when there is a
determination that the asset is impaired. The determination of fair
value for these assets is based on the best information available
that resides within Level 3 of the fair value hierarchy, including
internal cash flow estimates discounted at an appropriate interest
rate, quoted market prices when available, market prices for
similar assets and independent appraisals, as appropriate. For real
estate, cash flow estimates are based on current market estimates
that reflect current and projected lease profiles and available
industry information about expected trends in rental, occupancy and
capitalization rates.
15. Commitments and Contingencies
Warranties:
The Company offers warranties on the sales of certain of its
products and records an accrual for estimated future claims. Such
accruals are based upon historical experience and management’s
estimate of the level of future claims. The following table
presents changes in the Company’s product warranty liability (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2022 |
|
March 31, 2021 |
Balance at beginning of period |
|
$ |
1.3 |
|
|
$ |
1.2 |
|
|
|
|
|
|
Charged to operations |
|
0.2 |
|
|
0.6 |
|
Claims settled |
|
(0.2) |
|
|
(0.3) |
|
Balance at end of period |
|
$ |
1.3 |
|
|
$ |
1.5 |
|
Contingencies:
The Company's subsidiaries are involved in
various unresolved legal actions, administrative proceedings and
claims in the ordinary course of business involving, among other
things, product liability, commercial, employment, workers'
compensation, intellectual property claims and environmental
matters. The Company establishes accruals in a manner that is
consistent with accounting principles generally accepted in the
United States for costs associated with such matters when liability
is probable and those costs are capable of being reasonably
estimated. Although it is not possible to predict with certainty
the outcome of these unresolved legal actions or the range of
possible loss or recovery, based upon current information,
management believes the eventual outcome of these unresolved legal
actions, either individually or in the aggregate, will not have a
material adverse effect on the financial position, results of
operations or cash flows of the Company.
Certain Company subsidiaries are subject to
asbestos litigation. As of March 31, 2022, Zurn and numerous
other unrelated companies were defendants in approximately 6,000
asbestos related lawsuits representing approximately 7,000 claims.
Plaintiffs' claims allege personal injuries caused by exposure to
asbestos used primarily in industrial boilers formerly manufactured
by a segment of Zurn. Zurn did not manufacture asbestos or asbestos
components. Instead, Zurn purchased them from suppliers. These
claims are being handled pursuant to a defense strategy funded by
insurers.
As of March 31, 2022, the Company
estimates the potential liability for the asbestos-related claims
described above, as well as the claims expected to be filed in the
next ten years, to be approximately $66.0 million, of which
Zurn expects its insurance carriers to pay approximately
$49.0 million in the next ten years on such claims, with the
balance of the estimated liability being paid in subsequent years.
The $66.0 million was developed based on actuarial studies and
represents the projected indemnity payout for current and future
claims. There are inherent uncertainties involved in estimating the
number of future asbestos claims, future settlement costs, and the
effectiveness of defense strategies and settlement initiatives. As
a result, actual liability could differ from the estimate described
herein and could be substantial. The liability for the
asbestos-related claims is recorded in reserve for asbestos claims
within the condensed consolidated balance sheets.
Management estimates that its available
insurance to cover this potential asbestos liability as of
March 31, 2022 is in excess of the ten year estimated
exposure, and accordingly, believes that all current claims are
covered by insurance.
As of March 31, 2022, the Company had
a recorded receivable from its insurance carriers of
$66.0 million, which corresponds to the amount of this
potential asbestos liability that is covered by available insurance
and is currently determined to be probable of recovery. However,
there is no assurance the Company's current insurance coverage will
ultimately be available or that this asbestos liability will not
ultimately exceed the Company's coverage limits. Factors that could
cause a decrease in the amount of available coverage or create gaps
in coverage include: changes in law governing the policies,
potential disputes and settlements with the carriers regarding the
scope of coverage, and insolvencies of one or more of the Company's
carriers. The receivable for probable asbestos-related recoveries
is recorded in insurance for asbestos claims within the condensed
consolidated balance sheets.
16. Retirement Benefits
The components of net periodic benefit cost are as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
|
|
Pension Benefits: |
|
|
|
|
|
|
|
|
Service cost |
|
$ |
— |
|
|
$ |
0.1 |
|
|
|
|
|
Interest cost |
|
2.1 |
|
|
3.7 |
|
|
|
|
|
Expected return on plan assets |
|
(2.4) |
|
|
(4.9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
(0.3) |
|
|
$ |
(1.1) |
|
|
|
|
|
Other Postretirement Benefits: |
|
|
|
|
|
|
|
|
Interest cost |
|
$ |
0.1 |
|
|
$ |
0.1 |
|
|
|
|
|
Amortization: |
|
|
|
|
|
|
|
|
Prior service credit |
|
— |
|
|
(0.1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
0.1 |
|
|
$ |
— |
|
|
|
|
|
The service cost component of net periodic
benefits is presented within Cost of sales and Selling, general and
administrative expenses in the condensed consolidated statements of
operations, while the other components of net periodic benefit cost
are presented within Other income, net. The Company recognizes the
net actuarial gains or losses in excess of the corridor in
operating results during the final quarter of each fiscal year (or
upon any required re-measurement event).
During the three months ended
March 31, 2022 and March 31, 2021, the Company made
contributions of $0.2 million and $0.1 million,
respectively, to its qualified pension plan trusts.
Prior year amounts disclosed within this
note include amounts attributable to the Company's discontinued
operations, unless otherwise noted. Refer to Note 4 Discontinued
Operations for further detail.
See Note 16, Retirement Benefits, to the audited consolidated
financial statements included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2021 for further
information regarding retirement benefits.
17. Stock-Based Compensation
The Zurn Water Solutions Corporation
Performance Incentive Plan (the "Plan") is utilized to provide
performance incentives to the Company's officers, employees,
directors and certain others by permitting grants of equity awards
(for common stock), as well as performance-based cash awards, to
such persons to encourage them to maximize Zurn's performance and
create value for Zurn's stockholders. For the three months ended
March 31, 2022 and March 31, 2021, the Company recognized
$3.9 million and $9.1 million of stock-based compensation
expense, respectively.
During the three months ended March 31, 2022, the Company
granted the following restricted stock units, performance stock
units and common stock to directors, executive officers, and
certain other employees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Award Type |
|
Number of Awards |
|
Weighted Average Grant-Date Fair Value |
|
|
|
|
|
Restricted stock units |
|
7,406 |
|
|
$ |
33.17 |
|
Performance stock units |
|
5,244 |
|
|
$ |
33.37 |
|
Common stock |
|
13,796 |
|
|
$ |
35.50 |
|
See Note 15, Stock-Based Compensation, to
the audited consolidated financial statements included in the
Company's Annual Report on Form 10-K for the year ended
December 31, 2021, for further information regarding
stock-based compensation.
ITEM 2.
MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
General
Zurn is a growth-oriented, pure-play water
business that designs, procures, manufactures, and markets what we
believe is the broadest sustainable product portfolio of water
management solutions to improve health, human safety and the
environment. Our product portfolio includes professional grade
water control and safety, water distribution and drainage, finish
plumbing, hygienic and environmental and site works products for
public and private spaces. Our heritage of innovation and
specification has allowed us to provide highly-engineered,
mission-critical solutions to customers for decades and affords us
the privilege of having long-term, valued relationships with market
leaders. We operate in a disciplined way and the Zurn Business
System (“ZBS”) is our operating philosophy. Grounded in the spirit
of continuous improvement, ZBS creates a scalable, process-based
framework that focuses on driving superior customer satisfaction
and financial results by targeting world-class operating
performance throughout all aspects of our business.
The following information should be read in conjunction with the
audited consolidated financial statements and notes thereto, along
with Item 7, Management's Discussion and Analysis of Financial
Condition and Results of Operations (“MD&A”), in our Annual
Report on Form 10-K for the year ended December 31,
2021.
Critical Accounting Policies and Estimates
The condensed consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the United States ("GAAP"), which
require us to make estimates and assumptions that affect the
reported amounts of assets and liabilities on the date of the
financial statements and revenues and expenses during the periods
reported. Actual results could differ from those estimates. Refer
to Item 7, MD&A of our Annual Report on Form 10-K for the
year ended December 31, 2021 for information with respect to
our critical accounting policies, which we believe could have the
most significant effect on our reported results and require
subjective or complex judgments by management. Except for the items
reported below, management believes that as of March 31, 2022,
and during the period from January 1, 2022 through
March 31, 2022, there has been no material change to this
information.
Recent Accounting Pronouncements
See Item 1, Note 1, Basis of Presentation
and Significant Accounting Policies regarding recent accounting
pronouncements.
Elkay Merger
On February 12, 2022, we entered into a definitive agreement to
combine with Elkay Manufacturing Company (“Elkay”), pursuant to an
Agreement and Plan of Merger (the “Merger Agreement”) by and among
Zurn, Elkay, Zebra Merger Sub, Inc., a wholly-owned subsidiary of
Zurn (“Merger Sub”), and Elkay Interior Systems International,
Inc., as representative of the stockholders of Elkay. The Merger
Agreement provides that among other matters, and subject to the
satisfaction or waiver of the conditions set forth in the Merger
Agreement, Elkay would merge with Merger Sub, with Elkay surviving
as a wholly-owned subsidiary of Zurn (the “Merger”). Pursuant to
the terms and subject to the conditions set forth in the Merger
Agreement, at the effective time of the Merger (the “Effective
Time”), we will exchange, for 100% of the outstanding equity of
Elkay, up to 52.5 million newly issued shares of our common stock,
which on a pro forma basis, assuming closing of the Merger on
December 31, 2021 (and assuming no adjustments pursuant to the
Merger Agreement), would have represented approximately 29% of the
outstanding shares of the Company's common stock on a fully diluted
basis as of such date (the “Merger Consideration”).
We anticipate the Merger will close early in the third quarter of
2022. The closing of the Merger is subject to customary conditions,
including, among others, the absence of laws or orders by a
governmental authority enjoining or prohibiting the consummation of
the transactions contemplated by the Merger Agreement; the
expiration or termination of the applicable waiting period under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (“HSR”) (which waiting period expired on March 30, 2022);
the required approvals by the respective stockholders of Zurn and
Elkay; a registration statement having become effective in
accordance with the provisions of the Securities Act of 1933, as
amended, and not being subject to any stop order suspending the
registration statement (registration statement became effective on
April 26, 2022); the shares of our common stock to be issued in the
Merger being approved for listing on the New York Stock Exchange as
of the closing; the accuracy of the parties’ representations and
warranties contained in the Merger Agreement (subject to certain
materiality qualifications); the parties’ compliance with the
covenants and agreements in the Merger Agreement in all material
respects; and the absence of any material adverse effect on Zurn or
Elkay.
Acquisitions
On November 17, 2021, we completed the acquisition of the Wade
Drains business ("Wade Drains") from McWane, Inc. for a preliminary
cash purchase price of $13.7 million, excluding transaction
costs and net of cash acquired. The preliminary purchase price is
subject to customary post-closing adjustments. Wade Drains
manufactures a wide range of specified commercial plumbing products
for customers across North America and complements the Company's
existing flow systems product portfolio.
On April 16, 2021, we acquired substantially all of the assets of
Advance Technology Solutions, LLC (d/b/a ATS GREASEwatch) ("ATS
GREASEwatch") for a total cash purchase price of $4.5 million.
ATS GREASEwatch, headquartered in Saginaw, Michigan, develops,
manufactures and markets remote tank monitoring devices, alarms,
software and services for various applications and provides
technology to enhance and expand our current product offerings
within our existing Water Management platform.
Spin-Off of Process & Motion Control Segment
On October 4, 2021, we completed a Reverse Morris Trust tax-free
spin-off transaction (the “Spin-off Transaction”) in which (i)
substantially all the assets and liabilities of our Process &
Motion Control ("PMC") business were transferred to a newly created
subsidiary, Land Newco, Inc. (“Land”), (ii) the shares of Land were
distributed to our stockholders pro rata, and (iii) Land was merged
with a subsidiary of Regal Rexnord Corporation (formerly known as
Regal Beloit Corporation), in which the stock of Land was converted
into a specified number of shares of Regal Rexnord Corporation in
accordance with the exchange ratio. Following completion of the
Spin-Off Transaction, our name was changed to “Zurn Water Solutions
Corporation” and the ticker symbol for our shares of common stock
trading on the New York Stock Exchange was changed to “ZWS”. During
the three months ended March 31, 2022, we received
$35.0 million from Regal Rexnord Corporation as a result of
the final working capital and cash balances at closing exceeded the
targets stipulated within the Spin-Off Transaction
agreement.
The operating results of PMC are reported as discontinued
operations in our condensed consolidated statements of operations
for all periods presented. The condensed consolidated statements of
cash flows for the period ended March 31, 2021 have not been
adjusted to separately disclose cash flows related to the
discontinued operations. See Item 1, Note 4, Discontinued
Operations for additional information on cash flows associated with
the discontinued operations.
The major components of the Income from discontinued operations,
net of tax presented in the condensed consolidated statements of
operations for the three months ended March 31, 2022 and
March 31, 2021, are as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, 2022 |
|
March 31, 2021 |
Net sales |
$ |
— |
|
|
$ |
320.9 |
|
Cost of sales |
— |
|
|
(201.4) |
|
Selling, general and administrative expenses |
— |
|
|
(61.6) |
|
|
|
|
|
Amortization of intangible assets |
— |
|
|
(3.3) |
|
Interest expense, net |
— |
|
|
(1.4) |
|
|
|
|
|
|
|
|
|
Actuarial loss on pension and postretirement benefit
obligations |
— |
|
|
— |
|
|
|
|
|
Other expense, net |
— |
|
|
(0.7) |
|
Income from discontinued operations before income tax |
— |
|
|
52.5 |
|
|
|
|
|
Income tax benefit (provision) |
0.8 |
|
|
(12.5) |
|
Equity method investment income |
— |
|
|
0.1 |
|
Non-controlling interest income |
— |
|
|
0.1 |
|
Income from discontinued operations, net of tax |
$ |
0.8 |
|
|
$ |
40.0 |
|
Results of Operations
Three Months Ended March 31, 2022 compared with the Three
Months Ended March 31, 2021:
Net sales
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
Change |
|
% Change |
Net Sales |
$ |
239.6 |
|
|
$ |
205.2 |
|
|
$ |
34.4 |
|
|
16.8 |
% |
Net sales were $239.6 million during the three months ended
March 31, 2022, an increase of 17% year over year. Excluding a
2% increase to net sales resulting from our prior-year acquisition,
core sales increased 15% year over year as all of our product
categories contributed to the sales growth.
Income from operations
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
Change |
|
% Change |
Income from operations |
$ |
43.9 |
|
|
$ |
24.0 |
|
|
$ |
19.9 |
|
|
82.9 |
% |
% of net sales |
18.3 |
% |
|
11.7 |
% |
|
6.6 |
% |
|
|
Income from operations was $43.9 million during the three months
ended March 31, 2022, or 18.3% of net sales. Income from
operations as a percentage of net sales increased by 660 basis
points primarily as a result of the favorable impact of
year-over-year sales growth (inclusive of price realization),
productivity savings, lower non-cash stock-based compensation
expense, lower intangible asset amortization and the year-over-year
change in the adjustment to state inventories at last-in-first-out
cost, all of which was partially offset by the year-over-year
increases in material and transportation costs, as well as
incremental growth and productivity investments.
Interest expense, net
Interest expense, net was $4.8 million
during the three months ended March 31, 2022, compared to
$9.6 million during the three months ended March 31,
2021. The decrease in interest expense as compared to the prior
year's period is primarily a result of the lower outstanding
borrowings following the Spin-Off Transaction refinancing. See Item
1, Note 13 Long-Term Debt for more information.
Other income, net
Other income, net during the three months
ended March 31, 2022 and 2021, was $0.3 million and
$0.3 million, respectively. Other income, net consists
primarily of foreign currency transaction gains and losses and the
non-service cost components associated with our defined benefit
plans.
Provision for income taxes
The income tax provision was $10.0 million for the three
months ended March 31, 2022, compared to $4.7 million for
the three months ended March 31, 2021. The effective income
tax rate for the three months ended March 31, 2022 was 25.4%
versus 32.0% for the three months ended March 31, 2021. The
effective income tax rate for the three months ended March 31,
2022 was above the U.S. federal statutory rate of 21% primarily due
to the accrual of foreign income taxes, which are generally above
the U.S. federal statutory rate, the accrual of additional income
taxes associated with compensation deduction limitations under
Section 162(m) of the Internal Revenue Code and the accrual of
various state income taxes, partially offset by the recognition of
certain previously unrecognized tax benefits due to the lapse of
the applicable statutes of limitations and income tax benefits
associated with share-based payments. The effective income tax rate
for the three months ended March 31, 2021 was above the U.S.
federal statutory rate of 21% primarily due to the accrual of
foreign income taxes, which are generally above the U.S. federal
statutory rate, the accrual of additional income taxes associated
with compensation deduction limitations under Section 162(m) of the
Internal Revenue Code, and the accrual of various state income
taxes, partially offset by the recognition of income tax benefits
associated with foreign-derived intangible income
(“FDII”).
On a quarterly basis, we review and analyze our valuation
allowances associated with deferred tax assets relating to certain
foreign and state net operating loss carryforwards as well as U.S.
federal and state capital loss carryforwards. In conjunction with
this analysis, we weigh both positive and negative evidence for
purposes of determining the proper balances of such valuation
allowances. Future changes to the balances of these valuation
allowances, as a result of our continued review and analysis, could
result in a material impact to the financial statements for such
period of change.
Net income attributable to Zurn common stockholders
Net
income attributable to Zurn common stockholders during the three
months ended March 31, 2022, was $30.2 million compared
to $50.0 million during the three months ended March 31,
2021. Diluted net income per share attributable to Zurn common
stockholders for the three months ended March 31, 2022 and
March 31, 2021, was $0.24 and $0.40, respectively, as a result
of the factors described above. Net income from discontinued
operations, net of tax, was $0.8 million for the three months ended
March 31, 2022 compared to $40.0 million for the three months
ended March 31, 2021. Diluted net income per share from
discontinued operations for the three months ended March 31,
2022 and March 31, 2021, was $0.01 and $0.32,
respectively.
Non-GAAP Financial Measures
Non-GAAP
financial measures are intended to supplement and not replace
financial measures prepared in accordance with GAAP. The following
non-GAAP financial measures are utilized by management in comparing
our operating performance on a consistent basis. We believe that
these financial measures are appropriate to enhance an overall
understanding of our underlying operating performance trends
compared to historical and prospective periods and our peers.
Management also believes that these measures are useful to
investors in their analysis of our results of operations and
provide improved comparability between fiscal periods as well as
insight into the compliance with our debt covenants. Non-GAAP
financial measures should not be considered in isolation from, or
as a substitute for, financial information calculated in accordance
with GAAP. Investors are encouraged to review the reconciliation of
these non-GAAP measures to their most directly comparable GAAP
financial measures.
Core sales
Core sales excludes the impact of
acquisitions (such as the Wade Drains acquisition), divestitures
and foreign currency translation. Management believes that core
sales facilitates easier and more meaningful comparisons of our net
sales performance with prior and future periods and to our peers.
We exclude the effect of acquisitions and divestitures because the
nature, size and number of acquisitions and divestitures can vary
dramatically from period to period and between us and our peers,
and can also obscure underlying business trends and make
comparisons of long-term performance difficult. We exclude the
effect of foreign currency translation from this measure because
the volatility of currency translation is not under management's
control.
EBITDA
EBITDA represents earnings before interest
and other debt related activities, taxes, depreciation and
amortization. EBITDA is presented because it is an important
supplemental measure of performance and it is frequently used by
analysts, investors and other interested parties in the evaluation
of companies in our industry. EBITDA is also presented and compared
by analysts and investors in evaluating our ability to meet debt
service obligations. Other companies in our industry
may calculate EBITDA differently. EBITDA is not a measurement
of financial performance under GAAP and should not be considered as
an alternative to cash flow from operating activities or as a
measure of liquidity or an alternative to net income as indicators
of operating performance or any other measures of performance
derived in accordance with GAAP. Because EBITDA is calculated
before recurring cash charges, including interest expense and
taxes, and is not adjusted for capital expenditures or other
recurring cash requirements of the business, it should not be
considered as a measure of discretionary cash available to invest
in the growth of the business.
Adjusted EBITDA
Adjusted EBITDA (as described below in
“Covenant Compliance”) is an important measure because, under our
credit agreement, our ability to incur certain types of acquisition
debt and certain types of subordinated debt, make certain types of
acquisitions or asset exchanges, operate our business and make
dividends or other distributions, all of which will impact our
financial performance, is impacted by our Adjusted EBITDA, as our
lenders measure our performance with a net first lien leverage
ratio by comparing our senior secured bank indebtedness to our
Adjusted EBITDA (see “Covenant Compliance” for additional
discussion of this ratio, including a reconciliation to our net
income). We reported net income attributable to Zurn common
stockholders in the three months ended March 31, 2022, of
$30.2 million and Adjusted EBITDA for the same period of
$52.0 million. See “Covenant Compliance” for a reconciliation
of Adjusted EBITDA to GAAP net income.
Covenant Compliance
Our credit agreement, which governs our
senior secured credit facilities, contains, among other provisions,
restrictive covenants regarding indebtedness, payments and
distributions, mergers and acquisitions, asset sales, affiliate
transactions, capital expenditures and the maintenance of certain
financial ratios. Payment of borrowings under the credit agreement
may be accelerated if there is an event of default. Events of
default include the failure to pay principal and interest when due,
a material breach of a representation or warranty, certain
non-payments or defaults under other indebtedness, covenant
defaults, events of
bankruptcy and a change of control. Certain covenants contained in
the credit agreement restrict our ability to take certain actions,
such as incurring additional debt or making acquisitions, if we are
unable to meet a maximum total net leverage ratio of 5.00 to 1.0 as
of the end of each fiscal quarter. At March 31, 2022, our net
leverage ratio was 2.36 to 1.0. Failure to comply with these
covenants could limit our long-term growth prospects by hindering
our ability to borrow under the revolver, to obtain future debt
and/or to make acquisitions.
“Adjusted EBITDA” is the term we use to
describe EBITDA as defined and adjusted in our credit agreement,
which is net income, adjusted for the items summarized in the table
below. Adjusted EBITDA is intended to show our unleveraged, pre-tax
operating results and therefore reflects our financial performance
based on operational factors, excluding non-operational, non-cash
or non-recurring losses or gains. In view of our debt level, it is
also provided to aid investors in understanding our compliance with
our debt covenants. Adjusted EBITDA is not a presentation made in
accordance with GAAP, and our use of the term Adjusted EBITDA
varies from others in our industry. This measure should not be
considered as an alternative to net income, income from operations
or any other performance measures derived in accordance with GAAP.
Adjusted EBITDA has important limitations as an analytical tool,
and should not be considered in isolation, or as a substitute for
analysis of our results as reported under GAAP. For example,
Adjusted EBITDA does not reflect: (a) our capital expenditures,
future requirements for capital expenditures or contractual
commitments; (b) changes in, or cash requirements for, our working
capital needs; (c) the significant interest expenses, or the cash
requirements necessary to service interest or principal payments,
on our debt; (d) tax payments that represent a reduction in cash
available to us; (e) any cash requirements for the assets being
depreciated and amortized that may have to be replaced in the
future; or (f) the impact of earnings or charges resulting from
matters that we and the lenders under our credit agreement may not
consider indicative of our ongoing operations. In particular, our
definition of Adjusted EBITDA allows us to add back certain
non-cash, non-operating or non-recurring charges that are deducted
in calculating net income, even though these are expenses that may
recur, vary greatly and are difficult to predict and can represent
the effect of long-term strategies as opposed to short-term
results.
In addition, certain of these expenses can
represent the reduction of cash that could be used for other
corporate purposes. Further, although not included in the
calculation of Adjusted EBITDA below, the measure may at times
allow us to add estimated cost savings and operating synergies
related to operational changes ranging from acquisitions or
dispositions to restructuring, and/or exclude one-time transition
expenditures that we anticipate we will need to incur to realize
cost savings before such savings have occurred.
The calculation of Adjusted EBITDA under
our credit agreement as of March 31, 2022, is presented in the
table below. However, the results of such calculation could differ
in the future based on the different types of adjustments that may
be included in such respective calculations at the
time.
Set forth below is a reconciliation of net
income attributable to Zurn common stockholders to Adjusted EBITDA
for the periods indicated below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
Three months ended
March 31, 2021 |
|
Twelve months ended
December 31, 2021 |
|
Three months ended
March 31, 2022 |
|
Twelve months ended
March 31, 2022 |
Net income attributable to Zurn common stockholders |
$ |
50.0 |
|
|
$ |
120.9 |
|
|
$ |
30.2 |
|
|
$ |
101.1 |
|
Income from discontinued operations, net of tax (1) |
$ |
(40.0) |
|
|
(71.2) |
|
|
(0.8) |
|
|
(32.0) |
|
Provision for income taxes |
4.7 |
|
|
2.7 |
|
|
10.0 |
|
|
8.0 |
|
Actuarial gain on pension and postretirement benefit
obligations |
— |
|
|
(1.2) |
|
|
— |
|
|
(1.2) |
|
Other (income) expense, net (2) |
(0.3) |
|
|
0.7 |
|
|
(0.3) |
|
|
0.7 |
|
Loss on the extinguishment of debt |
— |
|
|
20.4 |
|
|
— |
|
|
20.4 |
|
Interest expense |
9.6 |
|
|
34.7 |
|
|
4.8 |
|
29.9 |
|
Depreciation and amortization |
8.3 |
|
|
32.7 |
|
|
5.3 |
|
|
29.7 |
|
EBITDA |
32.3 |
|
|
139.7 |
|
|
49.2 |
|
|
156.6 |
|
Adjustments to EBITDA |
|
|
|
|
|
|
|
Restructuring and other similar charges (3) |
0.6 |
|
|
3.7 |
|
|
1.1 |
|
|
4.2 |
|
Stock-based compensation expense |
9.1 |
|
|
37.5 |
|
|
3.9 |
|
|
32.3 |
|
LIFO expense (income) (4) |
1.7 |
|
|
14.1 |
|
|
(2.8) |
|
|
9.6 |
|
Acquisition-related fair value adjustment |
0.6 |
|
|
0.8 |
|
|
0.3 |
|
|
0.5 |
|
Other, net (5) |
— |
|
|
— |
|
|
0.3 |
|
|
0.3 |
|
Subtotal of adjustments to EBITDA |
12.0 |
|
|
56.1 |
|
|
2.8 |
|
|
46.9 |
|
Adjusted EBITDA |
$ |
44.3 |
|
|
$ |
195.8 |
|
|
$ |
52.0 |
|
|
$ |
203.5 |
|
Pro forma adjustment for acquisitions (6)
|
|
|
|
|
|
|
0.8 |
|
Pro forma Adjusted EBITDA |
|
|
|
|
|
|
204.3 |
|
Consolidated indebtedness (7) |
|
|
|
|
|
|
$ |
481.2 |
|
Total net leverage ratio (8) |
|
|
|
|
|
|
2.36 |
|
__________________________________
(1)Income
from discontinued operations, net of tax is not included in
Adjusted EBITDA in accordance with the terms of our credit
agreement.
(2)Other
(income) expense, net for the periods indicated, consists primarily
of gains and losses from foreign currency transactions and the
non-service cost components of net periodic benefit costs
associated with our defined benefit plans.
(3)Restructuring
and other similar charges is comprised of costs associated with
workforce reductions, lease termination costs, and other facility
rationalization costs. See Item 1, Note 3, Restructuring and
Other Similar Charges for more information.
(4)Last-in
first-out (LIFO) inventory adjustments are excluded in calculating
Adjusted EBITDA as defined in our credit agreement.
(5)Other,
net consists of gains and losses on the disposition of long-lived
assets.
(6)Represents
a pro forma adjustment to include Adjusted EBITDA related to the
acquisition of Wade Drains, which was permitted by our credit
agreement. The pro forma adjustment includes the period from April
1, 2021, through the date of the Wade Drains acquisition. See Item
1, Note 2, Acquisitions for more information.
(7)Our
credit agreement defines our consolidated indebtedness as the sum
of all indebtedness (other than letters of credit or bank
guarantees, to the extent undrawn) consisting of indebtedness for
borrowed money and capitalized lease obligations, less unrestricted
cash, which was $57.3 million (as defined by the credit agreement)
at March 31, 2022.
(8)Our
credit agreement defines the total net leverage ratio as the ratio
of consolidated indebtedness (as described above) to Adjusted
EBITDA for the trailing four fiscal quarters.
Liquidity and Capital Resources
Our primary sources of liquidity are
available cash and cash equivalents, cash flow from operations, and
borrowing availability of up to $200.0 million under our
revolving credit facility.
As of March 31, 2022, we had
$73.2 million of cash and cash equivalents and $193.9 million
of additional borrowing capacity. As of March 31, 2022, the
available borrowings under our credit facility were reduced by $6.1
million due to outstanding letters of credit. As of
December 31, 2021, we had $96.6 million of cash and cash
equivalents and approximately $193.9 million of additional
borrowing capacity under our revolving credit
facility.
Our revolving credit facility is available to fund our working
capital requirements, capital expenditures and for other general
corporate purposes. We believe this resource is adequate for
expected needs.
Cash Flows
Cash flows for the period ended March 31,
2021 include our continuing operations and discontinued operations
for the entire period, while the period ended March 31, 2022 only
include the cash flows associated with continuing operations. Refer
to Item 1, Note 4, Discontinued Operations for further
information.
Cash (used for) provided by operating activities was $(53.9)
million and $71.3 million during the three months ended
March 31, 2022 and 2021, respectively. The change in year over
year operating cash flows was primarily the result of higher trade
working capital and the impact of timing of payments on accounts
payable and accrued expenses during the three months ended
March 31, 2022.
Cash provided by investing activities was
$35.5 million during the three months ended March 31, 2022
compared cash used for investing activities of $8.1 million during
the three months ended March 31, 2021. Investing activities
during the three months ended March 31, 2022, included $0.8
million of capital expenditures which was offset by the receipt of
$35.0 million from Regal Rexnord Corporation in connection with the
final net assets transferred in the PMC Spin-Off Translation and
the receipt of $1.3 million in connection with the sale of
certain long-lived assets. Investing activities during the three
months ended March 31, 2021, primarily included
$9.2 million of capital expenditures, partially offset by the
receipt of $0.7 million in connection with the sale of certain
long-lived assets and the receipt of $0.4 million in connection
with finalizing the acquisition date trade working capital
associated with our 2020 acquisition of Hadrian.
Cash used for financing activities was $5.2
million during the three months ended March 31, 2022, compared
to $9.4 million during the three months ended March 31, 2021.
During the three months ended March 31, 2022, we utilized a
net $1.4 million of cash for payments on outstanding debt,
$3.8 million for the payment of common stock dividends and
$0.5 million for the payment of withholding taxes on employees'
share-based awards. The three months ended March 31, 2022,
also includes $0.5 million of cash proceeds associated with
stock option exercises. During the three months
ended March 31, 2021, we utilized $0.5 million of cash
for payments on outstanding debt, $10.8 million for the payment of
common stock dividends and $0.9 million to repurchase common stock.
The three months ended March 31, 2021, also includes
$2.8 million of cash proceeds associated with stock option
exercises.
Indebtedness
As of March 31, 2022, we had $538.5
million of total indebtedness outstanding as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt at
March 31, 2022 |
|
Current Maturities of Debt |
|
Long-term
Portion |
Term loan (1) |
|
$ |
538.2 |
|
|
$ |
5.5 |
|
|
$ |
532.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance leases and other subsidiary debt |
|
0.3 |
|
|
0.1 |
|
|
0.2 |
|
Total |
|
$ |
538.5 |
|
|
$ |
5.6 |
|
|
$ |
532.9 |
|
___________________________________________
(1)Includes
unamortized debt issuance costs of $10.4 million at
March 31, 2022.
See Item 1, Note 13, Long-Term Debt for a description of our
outstanding indebtedness.
ITEM 3.
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk during the
normal course of business from changes in foreign currency exchange
rates and interest rates. The exposure to these risks is managed
through a combination of normal operating and financing activities
and at times derivative financial instruments in the form of
foreign currency forward contracts to cover certain known foreign
currency transactional risks. We also have historically entered
into interest rate derivatives to manage interest rate
fluctuations.
ITEM 4. CONTROLS AND PROCEDURES
We maintain a set of disclosure controls
and procedures that are designed to ensure that information
required to be disclosed in our Exchange Act reports is recorded,
processed, summarized and reported within the time periods
specified in the SEC's rules and forms.
We carried out an evaluation, under the
supervision and with the participation of management, including the
Chief Executive Officer and Chief Financial Officer, of the
effectiveness of the design and operation of our disclosure
controls and procedures pursuant to Rules 13a-15(f)
and 15d-15(f) of the Exchange Act. Based on that evaluation as
of March 31, 2022, the Chief Executive Officer and Chief
Financial Officer concluded that, as of such date, the Company's
disclosure controls and procedures are adequate and effective in
recording, processing, summarizing and reporting, on a timely
basis, information required to be disclosed by the Company in the
reports that it files or submits under the Exchange Act and that
such information is accumulated and communicated to the Company's
management, including the Chief Executive Officer and Chief
Financial Officer, in a manner allowing timely decisions regarding
required disclosure. As such, the Chief Executive Officer and Chief
Financial Officer concluded that our disclosure controls and
procedures were effective as of the period covered by this
report.
Because of its inherent limitations,
internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become
inadequate because of the changes in conditions, or that the degree
of compliance with the policies or procedures may
deteriorate.
There have been no changes in our internal
control over financial reporting that occurred during our last
fiscal quarter that have materially affected, or are reasonably
likely to materially affect, our internal control over financial
reporting.
PART II - OTHER INFORMATION
ITEM 1. LEGAL
PROCEEDINGS
See the information under the heading
"Commitments and Contingencies" in Note 15 to the condensed
consolidated financial statements contained in Part I, Item 1 of
this report, which is incorporated in this Part II, Item 1 by
reference.
ITEM 1A. RISK FACTORS
In addition to the risks and uncertainties discussed in this
quarterly report on Form 10-Q, particularly those disclosed in the
MD&A, see Part I, Item 1A, “Risk Factors,” in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2021.
There have been no material changes to the Risk Factors except as
set forth below:
Risks Related to the Merger with Elkay
There can be no assurances when or if the Merger will be
completed.
Although Zurn and Elkay expect to complete the Merger in early the
third quarter of 2022, there can be no assurances as to the exact
timing of completion of the Merger or that the Merger will be
completed at all. The completion of the Merger is subject to
numerous conditions, including, among others:
• the absence of any law, order or injunction prohibiting the
Merger;
• the accuracy of each party’s representations and
warranties;
• each party’s compliance with its covenants and agreements
contained in the Merger Agreement; and
• approval of the Merger share issuance proposal (the "Merger Share
Issuance Proposal") by the stockholders of Zurn and the Elkay
Merger proposal (the "Elkay Merger Proposal") by the stockholders
of Elkay.
There can be no assurance that the
conditions required to complete the Merger, some of which are
beyond the control of Zurn and Elkay, will be satisfied or waived
on the anticipated schedule, or at all.
Additionally, the Merger Agreement also provides for certain
termination rights for both Zurn and Elkay, including if the Merger
is not consummated on or before November 14, 2022, with an
extension of three months if the parties are awaiting approval
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (“HSR”) with such waiting period having expired on March
30, 2022, and if stockholders of Zurn fail to approve the Merger
Share Issuance Proposal or by either party if the other party
breaches the Merger Agreement, subject to the cure rights set forth
in the Merger Agreement.
Obtaining required approvals and satisfying closing conditions may
prevent or delay completion of the Merger.
The Merger is subject to a number of conditions to closing as
specified in the Merger Agreement. These closing conditions
include, among others, obtaining Zurn stockholder approval of the
Merger Share Issuance Proposal, obtaining Elkay stockholder
approval of the Merger Agreement and Merger, the listing on the
NYSE of the Zurn Common Stock issuable in accordance with the
Merger Agreement, and the absence of governmental restraints or
prohibitions preventing the consummation of the Merger. The
obligation of each of Zurn and Elkay to consummate the Merger is
also conditioned on, among other things, the accuracy of the
representations and warranties as set forth by the other party in
the Merger Agreement (subject to certain materiality
qualifications) and the performance by the other party, in all
material respects, of its obligations under the Merger Agreement
required to be performed at or prior to the Effective Time. The
required stockholder consents and approvals may not be obtained and
the required conditions to closing may not be satisfied, and, if
all required consents and approvals are obtained and the conditions
are satisfied, no assurance can be given as to the terms,
conditions and timing of such consents and approvals. Any delay in
completing the Merger could cause Zurn and Elkay not to realize, or
to be delayed in realizing, some or all of the benefits that Zurn
and Elkay expect to achieve if the Merger is successfully completed
within its expected time frame.
The market price for Zurn Common Stock following the completion of
the Merger may be affected by factors different from, or in
addition to, those that historically have affected or currently
affect the market prices of Zurn Common Stock.
Zurn’s businesses differ in some regards from those of Elkay and,
accordingly, the results of operations of Zurn following completion
of the Merger will be affected by some factors that are different
from those currently or historically affecting the results of
operations of Zurn. In addition, following the closing of the
Merger, Zurn may seek to raise additional equity financing through
one or more underwritten offerings and/or private placements and/or
rights offerings, or issue stock in connection with acquisitions,
which may result in downward pressure on the share price of the
Zurn Common Stock.
The opinions of Zurn’s financial advisor will not reflect changes
in circumstances between the signing of the Merger Agreement and
the completion of the Merger.
Zurn has received an opinion from its financial advisor in
connection with the signing of the Merger Agreement, but will not
obtain an updated opinion prior to the closing of the Merger.
Changes in the operations and prospects of Zurn or Elkay, general
market and economic conditions and other factors that may be beyond
the control of Zurn, and on which Zurn’s financial advisor's
opinions was based, may significantly alter the value of Zurn or
Elkay or the price of the shares of Zurn Common Stock by the time
the Merger is completed. The opinion does not speak as of the time
the merger will be completed or as of any date other than the date
of such opinion.
Zurn and Elkay may be adversely affected by negative publicity
related to the proposed Merger and in connection with other
matters.
From time to time, political and public sentiment in connection
with the proposed Merger and in connection with other matters could
result in a significant amount of adverse press coverage and other
adverse public statements affecting Zurn and/or Elkay. Adverse
press coverage and other adverse statements, whether or not driven
by political or public sentiment, may also result in investigations
by regulators, legislators and law enforcement officials or in
legal claims. Responding to these investigations and lawsuits,
regardless of the ultimate outcome of the proceeding, can divert
the time and effort of senior management from the management of
Zurn’s and Elkay’s respective businesses. Addressing any adverse
publicity, governmental scrutiny or enforcement or other legal
proceedings is time consuming and expensive and, regardless of the
factual basis for the assertions being made, can have a negative
impact on the reputation of Zurn and Elkay, on the morale and
performance of their employees and on their relationships with
their respective regulators. It may also have a negative impact on
their ability to take timely advantage of various business and
market opportunities. The direct and indirect effects of negative
publicity, and the demands of responding to and addressing it, may
have a material adverse effect on Zurn’s and Elkay’s respective
businesses, financial condition, results of operations and cash
flows.
Failure to complete the Merger could have material and adverse
effects on Zurn.
If the Merger is not completed, due to the inability to satisfy any
of the closing conditions or for any other reason, Zurn’s ongoing
business may be adversely affected and, without realizing any of
the benefits of having completed the Merger, Zurn will be subject
to a number of risks, including the following:
• Zurn will be required to pay its costs relating to the Merger,
such as legal and accounting, whether or not the Merger is
completed;
• time and resources committed by Zurn’s management and employees
to matters relating to the Merger could otherwise have been devoted
to pursuing other beneficial opportunities; and
• the market price of the Zurn Common Stock could decline to the
extent that the current market price reflects a market assumption
that the Merger will be completed.
In addition to the above risks, if the
Merger Agreement is terminated under certain circumstances and the
Zurn Board of Directors seeks another acquisition, Zurn may be
required to pay Elkay a termination fee of $50.0
million.
Zurn may waive one or more of the closing conditions without
re-soliciting stockholder approval.
Zurn may determine to waive, in whole or part, one or more of the
conditions to closing the Merger prior to Zurn being obligated to
consummate the Merger. Zurn currently expects to evaluate the
materiality of any waiver and its effect on stockholders in light
of the facts and circumstances at the time, to determine whether
any re-solicitation of proxies is required in light of such waiver.
Any determination whether to waive any condition to the Merger or
to re-solicit stockholder approval will be made by Zurn at the time
of such waiver based on the facts and circumstances as they exist
at that time.
Zurn and Elkay will be subject to business uncertainties while the
Merger is pending, which could adversely affect their respective
businesses.
In connection with the pendency of the Merger, it is possible that
certain persons with whom Zurn or Elkay have a business
relationship may delay or defer certain business decisions or might
decide to seek to terminate, change or renegotiate their
relationships with Zurn or Elkay, as the case may be, as a result
of the Merger, which could negatively affect Zurn’s or Elkay’s
revenues, earnings and cash flows as well as the market price of
the Zurn Common Stock, regardless of whether the Merger is
completed. Also, Zurn’s and Elkay’s ability to attract, retain and
motivate employees may be impaired until the Merger is completed,
and Zurn’s ability to do so may be impaired for a period of time
thereafter, as current and prospective employees may experience
uncertainty about their roles within Zurn following the
Merger.
Under the terms of the Merger Agreement, Zurn and Elkay are subject
to certain restrictions on the conduct of business prior to the
consummation of the Merger, which may adversely affect Zurn’s and
Elkay’s ability to execute certain of Zurn’s and Elkay’s business
strategies, including the ability in certain cases to modify or
enter into certain contracts, acquire or dispose
of certain assets, incur or prepay certain indebtedness, incur
encumbrances, make capital expenditures or settle claims. Such
limitations could negatively affect Zurn’s and Elkay’s businesses
and operations prior to the completion of the Merger.
Zurn and Elkay will incur significant transaction costs in
connection with the Merger.
Zurn and Elkay have incurred and are expected to continue to incur
a number of non-recurring costs associated with the Merger,
combining the operations of Elkay with Zurn’s and achieving desired
synergies. These costs have been, and will continue to be,
substantial and, in many cases, each of Zurn and Elkay would bear
its own transaction costs whether or not the Merger is completed. A
substantial majority of non-recurring expenses will consist of
transaction costs and include, among others, fees paid to
financial, legal, accounting and other advisors and employee
retention, severance, and benefit costs. Zurn will also incur costs
related to formulating and implementing integration plans. Although
Zurn expects that the elimination of duplicative costs, as well as
the realization of synergies and efficiencies related to the
integration of the assets and operations of Elkay, should allow
Zurn to offset these transaction costs over time, this net benefit
may not be achieved in the near term or at all. Moreover, if the
Merger is not completed, Zurn will have incurred substantial
expenses for which no ultimate benefit will have been received.
Zurn and Elkay have incurred out-of-pocket expenses in connection
with the Merger for investment banking, legal and accounting fees
and financial printing and other costs and expenses, much of which
will be incurred even if the Merger is not completed.
Until the completion of the Merger or the termination of the Merger
Agreement in accordance with its terms, Zurn and Elkay are each
prohibited from entering into certain transactions and taking
certain actions that might otherwise be beneficial to Zurn or Elkay
and their respective stockholders.
From and after the date of the Merger Agreement and prior to
completion of the Merger, the Merger Agreement restricts Zurn and
Elkay from taking specified actions without the consent of the
other party and generally requires that the business of each
company and its respective subsidiaries be conducted in all
material respects in the ordinary course of business consistent
with past practice. These restrictions may prevent Zurn or Elkay
from making appropriate changes to their respective businesses or
organizational structures or from pursuing attractive business
opportunities that may arise prior to the completion of the Merger
and could have the effect of delaying or preventing other strategic
transactions. Adverse effects arising from the pendency of the
Merger could be exacerbated by any delays in consummation of the
Merger or termination of the Merger Agreement.
Securities class action and derivative lawsuits may be brought
against Zurn and/or Elkay in connection with the Merger, which
could result in substantial costs and may delay or prevent the
Merger from being completed.
Securities class action lawsuits and derivative lawsuits are often
brought against companies that have entered into acquisition,
merger or other business combination agreements that could prevent
or delay the completion of the Merger and result in significant
costs to Zurn and/or Elkay, including any costs associated with the
indemnification of directors and officers. Even if such a lawsuit
is without merit, defending against these claims can result in
substantial costs and divert management time and resources. An
adverse judgment could result in monetary damages, which could have
a negative impact on Zurn’s and/or Elkay’s liquidity and financial
condition.
Lawsuits that may be brought against Zurn, Elkay or Zurn’s or
Elkay’s directors could also seek, among other things, injunctive
relief or other equitable relief, including a request to enjoin
Zurn from consummating the Merger. One of the conditions to the
closing of the Merger is that no injunction by any court or other
tribunal of competent jurisdiction has been entered and continues
to be in effect and no law has been adopted or is effective, in
either case that prohibits or makes illegal the closing of the
Merger. Consequently, if a plaintiff is successful in obtaining an
injunction prohibiting completion of the Merger, that injunction
may delay or prevent the Merger from being completed within the
expected timeframe or at all, which may adversely affect Zurn’s
business, financial position and results of operation.
Zurn may record goodwill and other intangible assets that could
become impaired and result in material non-cash charges to the
results of operations of the combined company in the
future.
Zurn will account for the Merger as an acquisition of a business in
accordance with GAAP. Under the acquisition method of accounting,
the assets and liabilities of Elkay and its subsidiaries will be
recorded, as of the completion of the Merger, at their respective
fair values and added to Zurn’s. Zurn’s reported financial
condition and results of operations for periods after completion of
the Merger will reflect Elkay’s balances and results after
completion of the Merger but will not be restated retroactively to
reflect the historical financial position or results of operations
of Elkay and its subsidiaries for periods prior to the
Merger.
Under the acquisition method of accounting, the total purchase
price will be allocated to Elkay’s tangible assets and liabilities
and identifiable intangible assets based on their fair values as of
the date of completion of the Merger. The excess of the purchase
price over those fair values, if any, will be recorded as goodwill.
To the extent the value of goodwill or intangibles, if any, becomes
impaired in the future, Zurn may be required to incur material
non-cash charges relating to such impairment.
Zurn’s operating results may be significantly impacted from both
the impairment and the underlying trends in the business that
triggered the impairment.
If the Merger is consummated, Zurn may be unable to successfully
integrate Elkay’s business into its business or achieve the
anticipated benefits of the Merger.
The success of the Merger will depend, in part, on Zurn’s ability
to realize the anticipated benefits and cost savings from combining
Zurn’s and Elkay’s businesses, and there can be no assurance that
Zurn will be able to successfully integrate or otherwise realize
the anticipated benefits of the Merger. Difficulties in integrating
Zurn and Elkay may result in Zurn performing differently than
expected, in operational challenges, or in the failure to realize
anticipated expense-related efficiencies or other synergies.
Potential difficulties that may be encountered in the integration
process include, among others:
• the inability to successfully integrate Elkay in a manner that
permits the achievement of full revenue, expected cash flows and
cost savings anticipated from the Merger;
• not realizing anticipated synergies;
• integrating personnel from Elkay and the loss of key
employees;
• potential unknown liabilities and unforeseen expenses or delays
associated with and following the completion of the
Merger;
• integrating relationships with customers, vendors and business
partners;
• performance shortfalls as a result of the diversion of
management’s attention caused by completing the Merger and
integrating Elkay’s operations; and
• the disruption of, or the loss of momentum in, Zurn’s ongoing
business or inconsistencies in standards, controls, procedures and
policies.
Zurn may not be able to accomplish this
integration process successfully.
Our results may suffer if we do not effectively manage our expanded
operations following the Merger.
Following completion of the Merger, the size of Zurn’s business
will increase significantly beyond its current size. Zurn’s future
success will depend, in part, on Zurn’s ability to manage this
expanded business, which poses numerous risks and uncertainties,
including the need to integrate the operations and business of
Elkay into Zurn’s existing business in an efficient and timely
manner, to combine systems and management controls and to integrate
relationships with customers, vendors and business
partners.
Zurn’s current stockholders will have a reduced ownership and
voting interest after the Merger compared to their current
ownership and will exercise less influence over
management.
Immediately after the Merger is completed, it is expected that
Zurn’s current stockholders will collectively own approximately 71%
and the Elkay stockholders are expected to receive up to 52.5
million newly issued shares of Zurn Common Stock, which on a pro
forma basis assuming closing of the Merger on December 31, 2021
(and assuming no adjustments pursuant to the Merger Agreement),
would have represented approximately 29% of the outstanding shares
of Zurn Common Stock on a fully diluted basis as of such date. As a
result of the Merger, Zurn’s current stockholders will own a
smaller percentage of Zurn than they currently own, and as a result
will have less influence on Zurn’s management and
policies.
Sales of substantial amounts of the Zurn Common Stock in the open
market by the Elkay Stockholders could depress Zurn’s stock
price.
The former Elkay stockholders may wish to dispose of some or all of
the Zurn Common Stock that they receive in the Merger, and as a
result may seek to sell their Zurn Common Stock. These sales (or
the perception that these sales may occur), coupled with the
increase in the outstanding number of shares of Zurn Common Stock,
may affect the market for, and the market price of, the Zurn Common
Stock in an adverse manner.
If the Merger is completed and Zurn’s stockholders, including the
former Elkay stockholders, sell substantial amounts of Zurn Common
Stock in the public market following the closing of the Merger, the
market price of the Zurn Common Stock may decrease. These sales
might also make it more difficult for Zurn to raise capital by
selling equity or equity-related securities at a time and price
that it otherwise would deem appropriate.
Certain stockholders of Elkay will have registration rights, the
exercise of which could adversely affect the trading price of Zurn
Common Stock.
Concurrently with the closing of the Merger, Zurn and certain
stockholders of Elkay will enter into a Registration Rights
Agreement, pursuant to which Zurn will grant such stockholders a
right to demand registration of one public offering within the
first three years after the closing of the Merger, subject to
certain minimum and maximum thresholds and other customary
conditions. Zurn will pay certain expenses of the parties incurred
in connection with the exercise of their rights under the
Registration Rights Agreement and indemnify them for certain
securities law matters in connection with any registration
statement. The existence and potential or actual exercise of such
rights, and the perception that a large number of shares will be
publicly sold in the market, could adversely impact the trading
price of Zurn Common Stock.
ITEM 2. UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In fiscal 2015, the Company's Board of Directors approved a stock
repurchase program (the "Repurchase Program") authorizing the
repurchase of up to $200.0 million of the Company's common stock
from time to time on the open market or in privately negotiated
transactions. On January 27, 2020, the Company's Board of Directors
increased the remaining share repurchase authority under the
Repurchase Program to $300.0 million. The Repurchase Program does
not require the Company to acquire any particular amount of common
stock and does not specify the timing of purchases or the prices to
be paid; however, the program will continue until the maximum
amount of dollars authorized have been expended or until it is
modified or terminated by the Board. The Company did not repurchase
any shares during the three months ended March 31, 2022. A
total of approximately $162.8 million of the existing repurchase
authority remained under the Repurchase Program at March 31,
2022.
ITEM 6. EXHIBITS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
No. |
|
Description |
|
Filed
Herewith |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1 |
|
|
|
|
|
|
10.1 |
|
|
|
|
|
|
10.2 |
|
|
|
|
|
|
10.3 |
|
|
|
|
|
|
31.1 |
|
|
|
X |
|
|
|
|
|
|
|
|
|
31.2 |
|
|
|
X |
|
|
|
|
|
|
|
|
|
32.1 |
|
|
|
X |
|
|
|
|
|
|
|
|
|
101.INS |
|
Inline XBRL Instance Document (The instance document does not
appear in the interactive data file because its XBRL tags are
embedded within the inline XBRL document.) |
|
X |
|
|
|
|
|
|
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document |
|
X |
|
|
|
|
|
|
|
|
|
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase
Document |
|
X |
|
|
|
|
|
|
|
|
|
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase
Document |
|
X |
|
|
|
|
|
|
|
|
|
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document |
|
X |
|
|
|
|
|
|
|
|
|
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase
Document |
|
X |
|
|
|
|
|
|
|
|
|
104 |
|
Cover Page Inline XBRL data (contained in Exhibit 101) |
|
X |
|
|
*Incorporated by reference to the same exhibit number in the
Company's Current Report on Form 8-K, dated February 12,
2022.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, Zurn Water Solutions Corporation
has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ZURN WATER SOLUTIONS CORPORATION |
|
|
|
|
|
Date: |
April 27, 2022 |
|
By: |
/S/
MARK W. PETERSON
|
|
|
|
Name: |
Mark W. Peterson |
|
|
|
Title: |
Senior Vice President and Chief Financial Officer |
Zurn Water Solutions (NYSE:ZWS)
Historical Stock Chart
Von Jun 2022 bis Jul 2022
Zurn Water Solutions (NYSE:ZWS)
Historical Stock Chart
Von Jul 2021 bis Jul 2022